WO2006076844A1 - Traditional chinese medicament for treating injuries from falls, rheumatism and ostealgia and method for manufacture thereof - Google Patents

Traditional chinese medicament for treating injuries from falls, rheumatism and ostealgia and method for manufacture thereof Download PDF

Info

Publication number
WO2006076844A1
WO2006076844A1 PCT/CN2005/001679 CN2005001679W WO2006076844A1 WO 2006076844 A1 WO2006076844 A1 WO 2006076844A1 CN 2005001679 W CN2005001679 W CN 2005001679W WO 2006076844 A1 WO2006076844 A1 WO 2006076844A1
Authority
WO
WIPO (PCT)
Prior art keywords
traditional chinese
chinese medicine
group
medicine preparation
ethanol
Prior art date
Application number
PCT/CN2005/001679
Other languages
French (fr)
Chinese (zh)
Inventor
Feiyan Wei
Original Assignee
Guangxi Huahong Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangxi Huahong Pharmaceutical Co., Ltd. filed Critical Guangxi Huahong Pharmaceutical Co., Ltd.
Publication of WO2006076844A1 publication Critical patent/WO2006076844A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/26Aristolochiaceae (Birthwort family), e.g. heartleaf
    • A61K36/268Asarum (wild ginger)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A61K31/125Camphor; Nuclear substituted derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/21Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/238Saposhnikovia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/254Acanthopanax or Eleutherococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/27Asclepiadaceae (Milkweed family), e.g. hoya
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/289Vladimiria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/46Eucommiaceae (Eucommia family), e.g. hardy rubber tree
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/538Schizonepeta
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/54Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/59Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/74Rubiaceae (Madder family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/74Rubiaceae (Madder family)
    • A61K36/744Gardenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/83Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
    • A61K36/835Aquilaria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/85Verbenaceae (Verbena family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/902Sparganiaceae (Bur-reed family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Definitions

  • the invention relates to a pharmaceutical preparation containing an active ingredient of a Chinese herbal medicine, in particular to a traditional Chinese medicine preparation for treating bruises and rheumatic bone pain and a preparation method thereof.
  • the object of the present invention is to provide a traditional Chinese medicine preparation which has remarkable curative effect, rapid action and small side effects for treating bruises and rheumatism.
  • Another object of the present invention is to provide a process for the preparation of the above-mentioned traditional Chinese medicine preparation.
  • the preparation of the traditional Chinese medicine preparation prepared by the invention has remarkable curative effect on bruises and rheumatoid bone pain, and is clinically applicable to, for example, wind-cold dampness, frozen shoulder, acute contusion, anonymous swollen poison, sputum, Glandular swelling and other diseases.
  • the pharmaceutical drug substances provided by the present invention are all in parts by weight.
  • the invention provides a Chinese medicine preparation for treating bruises and rheumatic bone pain as follows:
  • the preferred scheme of the traditional Chinese medicine preparation for treating bruises and rheumatic bone pain is as follows: windproof 30-80 Nepeta 30-80 Asarum 30-80
  • Another preferred embodiment of the traditional Chinese medicine preparation for treating bruises and rheumatic bone pain according to the present invention is: Windproof 30-80 Nepeta 30-80 Asarum 30-80
  • a further preferred embodiment of the traditional Chinese medicine preparation for treating bruises and rheumatic bone pain is: windproof 30-80 Nepeta 30-80 Asarum 30-80 Achyranthes 30-80 Chuanxi 30-80 Xu Changqing 30-80 30-80 ⁇ 85-120 ⁇ 55-90 ⁇ 85- 120 ⁇ 55-90 camphor 40-90 menthol 40-90 ⁇ 30-80 ⁇ 30-80 ⁇ 55-90 ⁇ 30-80 Wujiapi 30-80 Huangteng 80-105 Scorpion 85-120.
  • the most preferable scheme of the traditional Chinese medicine preparation for treating bruises and rheumatic bone pain is the windproof 30-80 Nepeta 30-80 Asarum 30-80 Achyranthes 30-80 Chuanxi 30-80 Xu Changqing 30-80 Qishu 30- 80 ⁇ 85-120 ⁇ 55-90 Double-sided needle 85-120 ⁇ 55-90 Camphor 40-90 Menthol 40-90 Guizhi 30-80 ⁇ 30 - 80 ⁇ 55-90 ⁇ 30- 80 five plus skin 30-80 yellow rattan 8G-105 scorpion 85-120 agarwood 20-40.
  • the traditional Chinese medicine preparation of the present invention may be any pharmaceutically acceptable dosage form prepared by a conventional formulation process in the art.
  • An expectorant, a liquid, an emulsion or the like is preferred.
  • the preferred ratio of the above-mentioned drug substance is:
  • the amount ratio of the above-mentioned drug substance is also preferably:
  • the preferred ratio of the above-mentioned drug substance is:
  • the traditional Chinese medicine tanning agent can be prepared according to the following preparation process:
  • the above raw materials such as camphor and menthol are pulverized into coarse powder according to the method of preparing a liquid extracting agent and an extracting agent (see Appendix 10 of the Chinese Pharmacopoeia 2000 edition). 7000 ⁇ 8000 parts by weight of 50-95% ethanol as solvent, after immersion for 15-30 hours, slowly ooze at a rate of about 1-10 ml per minute, collect sputum, and store it; take camphor, menthol plus After 500-800 parts by weight of 50-95% ethanol is dissolved, it is mixed with the above-mentioned mash, allowed to stand for 20-72 hours, and filtered to obtain.
  • the main active ingredient of the drug substance of the present invention and the action thereof are as follows: woody, wherein the Yunmuxiangcai contains volatile oil 0. '3 ⁇ 3%, wherein the components are single taxane, ⁇ -Rolandone, ⁇ -celery Isoene, scutellarin, citronella, eucaly, woody acid, woody alcohol, alpha-woody hydrocarbon, beta-woody hydrocarbon, woody lactone, decene, water phlegm, dehydrogenated woody Lactone, dihydrodehydroxylactone, and the like.
  • the roots also contain sterol, betulin, resin, inulin and eucalyptus.
  • Its pharmacological effects are: 1 antispasmodic and antihypertensive effects, 2 antibacterial effects. Indications include qi and pain relief, warm stomach and stomach. Treatment of cold qi stagnation, chest and abdomen pain, vomiting, diarrhea, squatting in the squat, heavy, cold. Windproof, containing volatile oil, mannitol, bitter miso, etc. Its pharmacological effects are: 1 antipyretic effect, 2 analgesic effect, 3 antibacterial effect. The main function of the function is to publish, hurricane, win the wet, and relieve pain. Exogenous cold, headache, dizziness, strong, cold and dampness, sore throat, limbs urgency, tetanus.
  • Nepeta containing volatile oil 1.8%, the main component of the oil is dextrin, racemic menthone, a small amount of d-limonene. Its pharmacological effects are: artificially heated rabbits, oral schisandra and 2 grams of extract (raw drug) / kg, no heat. In vitro, high concentrations (1: 100) have the effect of anti-tuberculosis.
  • the main function of the function is to publish, hurricane, and blood; Treatment of cold fever, headache, sore throat, stroke sputum, vomiting blood, blood stasis, blood in the stool; uterine bleeding, postpartum blood halo; bloated, sore, phlegm.
  • Liao Xixin contains volatile oil, the main component of volatile oil is decyl eugenol, Others include xanthine, ⁇ -pinene, eucalyptone, phenolic substances, etc.; Hua Xixin contains volatile oil 2.75%, 1.9%. Volatile oil mainly contains decyl eugenol (about 50 ° /.), as well as asarone, terpene, eucalyptone, xanthine, 1, 8-alpha, I-asarone (about 0 . 2% ) and so on.
  • Huaxinxin and the composition of volatile oil are similar to those of Huaxin; the volatile oil of Asarum sinensis contains 6% of eucalyptone, 8% of borneol or lycopene, 4% of eucalyptus 4%, and 2% of lin.
  • Astragalus sinensis contains flavonoid glycosides, amino acids, sugars and volatile oils. Its pharmacological effects are: 1 local anesthetic effect, 2 antipyretic, analgesic effect, 3 antibacterial effect, 4 effects on blood pressure. Indications: Hurricane, cold, water, open.
  • Wujiapi, Wujia's root bar contains volatile oil (for 4-methyl salicylaldehyde, etc.), tannin, palmitic acid, linolenic acid and vitamin bismuth, B l D sessile root plus sesamin, sprinkle Ning, syrup resin phenolic monoglucoside (five plus bismuth B) and mannose glucoside (five plus ⁇ D) and other lignan components, also contains carotenol, cardiac sputum and saponin.
  • the root of Acanthopanax senticosus contains a variety of glycocalyx, including carrot sterol, 7-hydroxy-6, 8-dimethoxy coumarin ct-glucoside, ethyl alpha-galactose, syringe phenol glucoside, Lilac and so on. In addition, it also contains sesamin and polysaccharide (2.3 to 5. 7 ° /.). The stem contains sugar V. 6 ⁇ 1. 5%).
  • the fruit contains 17-20% water-soluble polysaccharide, which contains pectin shield.
  • Its pharmacological effects are: 1. Pharmacological action of sessile sessile plus 1 anti-inflammatory effect, 2 analgesic, antipyretic effect, 3 cardiovascular effects; Pharmacological action of Acanthopanax senticosus, Acanthopanax senticosus is better than ginseng "Adapt to the original, and the role of the function. Indications: Rheumatism, strong bones, blood circulation to go to the phlegm. Treatment of cold and dampness, rapid bones and muscles, low back pain, impotence, weak feet, late child, edema, athlete's foot, sore throat, swelling, pain, Bruises and bruises.
  • Guizhi its pharmacological effects are: 1 antibacterial effect, 2 antiviral effect, 3 diuretic use.
  • the main functions are: sweating and relieving muscles, warming the veins. Treatment of cold and cold syndrome, shoulder and back muscles are sore, chest and drink.
  • Achyranthes its root contains triterpenoid saponin, hydrolyzed to form oleanolic acid, and contains a lot of potassium salt.
  • the seeds also contain triterpenoid saponins, which are the same as those contained in the roots. It also contains ecdysterone, and cofone.
  • Its pharmacological effects are: 1 the effect on the uterus, 2 on the intestinal tract, 3 on the cardiovascular system, 4 analgesic effect.
  • the main function of the function is: the use of scattered blood, dissipate swelling. Gonorrhea, hematuria, amenorrhea, symptoms, dystocia, cytoplasmic, postpartum bloody abdominal pain, throat, bloated, bruises. Cooked liver and kidney, strong bones and muscles. Treating the waist and knee pain, hehe. Chuanxiong, its roots contain volatile oil, alkaloids, phenolic components, lactones, ferulic acid. Its pharmacological effects are: 1 the role of the central nervous system, 2 antihypertensive effect, 3 pairs of smooth muscle, 4 antibacterial effects. Function and Indications: Live blood, hurricane and pain.
  • Dry bark, function and indications hurricane active, strong waist and knees, strong bones, swelling.
  • Function and Indications Blood circulation and menstruation, hurricane dehumidification. Treatment of menstruation, dysmenorrhea, rheumatism, pain, bruises. Double-sided needle, function and indications: qi and pain, blood circulation, phlegm and wind.
  • Agarwood containing agarwood spirulina, a-agarfurfuran, B-agarfurfuran, dihydrofuran furan, demethylfuran, 4-hydroxydihydrofuran, 3,4-dihydroxydihydrofuran, eugenol;
  • Function and Indications Qi and pain, warm and stop vomiting, gas and asthma.
  • stomach cold vomiting hiccups For chest and abdomen swelling and pain, stomach cold vomiting hiccups, kidney deficiency gas and asthma.
  • the big Luo umbrella is used for swelling, relieving pain, phlegm, sputum, blood stasis, rheumatism, Xu Changqing, phlegm, pain relief, and collateral.
  • scorpion, two-sided needle, Chuanxiong, Achyranthes Such as activating blood circulation to remove phlegm, in order to strengthen the main medicine swelling and pain relief effect, and with cassia twig, schizonepeta, wind, spleen, wind and cold, woody, agarwood, white peony, camphor qi and pain, swelling and dampness, It is supplemented with Wujiapi, Eucommia with strong bones, Tongjingluo and Rheumatoid arthritis.
  • the yellow vine and the scorpion with the cold and cool products are used as the adjuvant for cooling blood and detoxification.
  • the opposite is multiplied.
  • It is then blended with menthol to repel and repel various medicines for use in the skin or mucous membranes to produce a cool feeling.
  • the combination of various medicines has the effects of reducing swelling and relieving pain, promoting blood circulation and removing blood stasis, driving wind and collaterals, and relieving cold and dampness. It is used for cold and dampness, frozen shoulder, and acute contusion.
  • the above-mentioned raw materials other than camphor and menthol are pulverized into coarse powder according to the method of preparing a liquid extracting agent and an extracting agent (see Appendix 10 of the Chinese Pharmacopoeia 2000 edition), using 7200 parts by weight of 85% ethanol as a solvent. After immersion for 15 hours, slowly percolate at a rate of about 5 ml per minute, collect the sputum, and store it again; take camphor and menthol and add 550 parts by weight of 75% ethanol to dissolve, mix with the above sputum, and let stand. After 28 hours, it was filtered to obtain the expectorant of the present invention.
  • Double-sided needle 110 Triangular 85 Camphor 90
  • the above raw materials other than camphor and menthol are pulverized into coarse powder, according to the method of preparing a liquid extracting agent and a leaching agent (see Appendix 10 of the Chinese Pharmacopoeia 2000 edition), using 7000 parts by weight of 53% ethanol as a solvent. After immersion for 15 hours, slowly percolate at a rate of about 5 ml per minute, collect the sputum, and store it again; take camphor and menthol and add 500 parts by weight of 95% ethanol to dissolve, mix with the above sputum, and let stand. After 20 hours, it was filtered to obtain the expectorant of the present invention.
  • the above raw materials other than camphor and menthol are pulverized into coarse powder.
  • the osmosis method of the agent and the extract (see Appendix 10 of the Chinese Pharmacopoeia 2000 edition), using 8000 parts by weight of 75% ethanol as a solvent, immersing for 30 hours, slowly oozing at a rate of about 3 ml per minute, collecting sputum, The device was preserved; the camphor and menthol were added with 800 parts by weight of 53% ethanol to dissolve, and then mixed with the above mash, allowed to stand for 24 hours, and filtered to obtain the elixirs of the present invention.
  • An emulsion is prepared according to a conventional formulation process in the art.
  • the other raw materials are pulverized into coarse powder, according to the percolation method for preparing the extract extract and the extract (see Appendix 10 of the Chinese Pharmacopoeia 2000 edition), using 7500 parts by weight of 95% ethanol as a solvent. , immersed for 28 hours, slowly permeate at a rate of about 3 ml per minute, collect sputum, recover alcohol, and obtain clear paste; take camphor, menthol and add 650 parts by weight of 70% ethanol to dissolve, mix with the above-mentioned clear paste After standing for 48 hours, filtering, adding 3000 parts by weight of water to adjust the water agent of the present invention.
  • the other raw materials are pulverized into coarse powder.
  • 7600 parts by weight of 79% ethanol is used as a solvent.
  • standing for 48 hours filtration, adding 8000 parts by weight of water to adjust the water agent of the present invention.
  • the other raw materials are pulverized into coarse powder.
  • 7500 parts by weight of 90% ethanol is used as a solvent.
  • immersed for 28 hours slowly permeate at a rate of about 3 ml per minute, collect sputum, recover alcohol, and obtain clear paste; take camphor, menthol and add 650 parts by weight of 70% ethanol to dissolve Thereafter, it was mixed with the above-mentioned clear paste and allowed to stand for 48 hours: filtered, and adjusted to 4500 parts by weight of water to obtain the aqueous preparation of the present invention.
  • the above nineteen flavored raw materials other than menthol are pulverized into coarse powder, according to the method of preparing the infiltrative paste and the extracting agent (see Appendix 10 of the Chinese Pharmacopoeia 2000 edition), using 7500 parts by weight 80% Ethanol as a solvent, immersed for 15 hours, slowly permeate at a rate of about 5 ml per minute, collect sputum, and store it again; take camphor, menthol and 600 parts by weight of 85% ethanol to dissolve, mix with the above mash After standing for 72 hours and filtering, the tincture of the present invention is obtained.
  • Agarwood 32. 5 camphor 55 menthol 55 The above nineteen flavors of the raw materials other than camphor and menthol are pulverized into coarse powder, according to the method of preparing the infiltrative paste and the extracting agent (see Appendix 10 of the Chinese Pharmacopoeia 2000 edition), using 7200 parts by weight 70% Ethanol as solvent, immersed for 15 hours, slowly permeate at a rate of about 5 ml per minute, collect sputum, and store it again; take camphor, menthol and add 700 parts by weight of 65% ethanol to dissolve, mix with the above mash After standing for 36 hours and filtering, the tincture of the present invention was obtained.
  • the above nineteen flavored raw materials other than camphor and menthol are pulverized into coarse powder according to the method of preparing a liquid extracting agent and an extracting agent (see Appendix 10 of the Chinese Pharmacopoeia 2000 edition), using 7800 parts by weight and 60%. Ethanol as a solvent, immersed for 15 hours, slowly permeate at a rate of about 5 ml per minute, collect sputum, and store it again; take camphor, menthol and add 700 parts by weight of 60% ethanol to dissolve, mix with the above mash After standing for 60 hours and filtering, the tincture of the present invention was obtained.
  • the above nineteen flavored raw materials other than camphor and menthol are pulverized into coarse powder according to the method of preparing the infiltrative solution of the flow extract and the extract (see Appendix 10 of the Chinese Pharmacopoeia 2000 edition), using 7500 parts by weight 80%.
  • Ethanol as a solvent immersed for 15 hours, slowly permeate at a rate of about 5 ml per minute, collect sputum, and store it again; take camphor, menthol and 600 parts by weight of 60% ethanol to dissolve, mix with the above mash After standing for 24 hours and filtering, the tanning agent of the present invention was obtained.
  • the pharmacodynamic test data of the traditional Chinese medicine preparation of the invention is as follows:
  • the anti-tumor and analgesic tincture is a traditional Chinese medicine preparation tincture developed by Guangxi Liuzhou Traditional Chinese Medicine General Factory.
  • Pharmacodynamic tests showed that: local application can significantly expand the capillaries of mouse ear canal, and obviously promote the absorption of blood spots in rabbit ears; local application and ig administration can inhibit the swelling and smallness of mouse ear canal caused by croton oil.
  • the drug has obvious analgesic effect on the stimulation of acetic acid in mice.
  • the topical application has the effect of promoting the repair of soft tissue contusion in mice.
  • the minimum inhibitory concentration against Escherichia coli in vitro is 1:10, against Staphylococcus aureus and B. Streptococcus is 1:20.
  • Test sample This product (batch number 940402) and its 2 times concentrated liquid (55% alcohol), provided by Liuzhou Chinese Medicine General Factory. The doses described herein are expressed in "this product ml”.
  • Kunming mice ordinary grade, ? ⁇ is used in combination, supplied by the animal room, feeding the pellet feed.
  • Escherichia coli 44102
  • Staphylococcus aureus 26003
  • Streptococcus mutans 32172
  • Bacterial culture medium common broth medium, eosin blue agar medium, mannitol high salt agar medium, blood lipid medium, serum broth medium, prepared by our antibiotic room according to the Ministry of Health "Drug Hygiene Test Method" .
  • Feng rheumatoid beaten medicinal liquor produced by Foshan Pharmaceutical First Factory, Guangdong, batch number 9309086, containing alcohol 35-45%. When used, it can be concentrated in 6 (TC water bath to half of the original volume, and part of the ethanol is removed, and water is added to the required volume.
  • Absolute ethanol produced by Anhui Super-Grade General Factory, batch number 9312 2 0. Dilute the appropriate concentration with deionized water for testing.
  • Croton oil mixed inflammatory agent This room is prepared. 0. 5% Evans Blue: This room is prepared. 0. 7% acetic acid This room is prepared.
  • CHEM-5 semi-automatic biochemical analyzer produced by Japan ERBA.
  • mice Take 50 mice, weighing 18-21g, ? S is used in combination, and is randomly divided into 5 groups. Each mouse was anesthetized with barbiturate sodium, and the left auricle was coated with paraffin oil on a glass slide. After anesthesia for 10 minutes, the auricle tip A was observed under a microscope equipped with a ruler (10 X 4 times). The diameter of the capillary at the branch (scale unit), as a pre-medication value, immediately administered: high and low dose group according to the product 0. 2ml / ear (use this product 2 times concentrated liquid 0. 1 / ear ), 0. 1ml / ear lightly on the auricle; ethanol group with 55% ethanol drop auricle.
  • the dosage volume of each group was 0.1 ml/ear.
  • the blood vessel diameter of the same site was observed every 5 minutes after the drug for 15 minutes.
  • the maximum value of the blood vessel diameter was used as the drug value.
  • the vasodilation rate and vasodilatation degree were calculated according to the following formula, and compared with the blank group, the t-test was performed between groups. The results are shown in Table 1.
  • Vasodilatation rate two female x simple
  • Vasodilatation post-drug value - pre-medication value
  • Blank group 10 0.1 3.35 ⁇ 0.47 0.10 ⁇ 0.21 3.1 ⁇ 6.5
  • each rabbit is used for subcutaneous blood spotting of the auricle: Inject 0.2 ml of anti-coagulant liquid into the blood mound under the skin of the ear, and press with a glass tube with an inner diameter of 1.6 cm. Around the blood dome, the blood core is gently pressed from the glass tube with a diameter of the front end of the curved section, forming an area of about 2CM 2 blood spots. Two blood spots per ear, about 3CM apart.
  • the area of each blood spot was measured as the pre-medication value, and the administration was as follows:
  • the high- and low-dose groups were respectively 0.2 ml/shift (0.1 ml/class of 2 times concentrated solution of this product), 0.1 ml/class This product; the positive control group and the blank control group were given 0. lml/ spot respectively to Feng medicinal liquor and deionized water; alcohol group to 55% ethanol 0.1 heml / spot, all blood spots (surface skin coating, Once a day.
  • the blood spot area was measured once every 24 hours after administration, and the blood spot absorption rate X 100% was calculated. The value before the drug was compared with the blank group to make an inter-group t test.
  • the difference of blood spot absorption rate at 48h, 72h and 96h was very significant.
  • the blood spot absorption rate of the low dose group was 48 h after the drug was higher than that of the blank group. The difference was significant.
  • the absorption of subcutaneous blood spots has a certain promoting effect.
  • mice Take 84 mice, weighing 22-24g, ? ⁇ is used in combination and is randomly divided into 7 groups.
  • 7 groups of mice ⁇ croton oil mixed inflammatory agent 0.1 1 / ear drops on both sides of the left auricle to cause inflammation.
  • the product group 1, the phosic group, the ethanol group, and the blank group were administered in the same way after 1, 2, and 3 hours after the inflammation; the second group and the third group of the product were the first group after the inflammation.
  • the same method is administered once more (5 ml of this product plus 55% ethanol is added to 10 ml for the third group, and the product is 2. 5 ml plus 55% ethanol to 10 ml for the fourth group). 4 hours after the inflammation, the mice were sacrificed by pulling the neck, and the left and right auricles were cut out.
  • the left and right ear slices were respectively punched in the corresponding parts with a diameter of 8 mm, and weighed separately. The difference between the left and right ear weights is used as the swelling degree, and the swelling rate is compared with the blank group.
  • the inhibitory effect of the outer coating on the swelling of the croton oil to the ear lobes showed a certain dose-effect relationship. It is suggested that the administration of the ear canal has a certain inhibitory effect on the swelling of the mouse ear canal caused by croton oil.
  • mice Take 72 mice, weighing 17-22g, ? ⁇ is used in combination, and is divided into 6 groups at random.
  • the high, medium and low dose groups are given 10ml/kg (5ml with twice the concentration of this product), 5ml/kg, 2. 5ml /kg respectively.
  • the group, the ethanol control group and the blank control were given 10 ml / kg of von red wine (spent part of ethanol, see material item), 27% ethanol 10 ml / kg, deionized water 10 ml / kg, and the volume of each group was 10 ml/kg, continuous ig administration for 2 days.
  • One hour after the administration of the overseas Chinese the left ear of each mouse was coated with croton without mixing inflammatory agent 0.
  • mice were sacrificed by pulling the neck, and the left and right ear lobes were cut. 8 wake up the puncher in the corresponding parts, respectively, the left and right ear discs, accurately weighed, the difference between the weight of the left ear and the weight of the right ear; the swelling rate, with ji3 ⁇ 4 as the swelling rate, and the blank group For comparison, a t-test between groups was performed. The results are shown in Table 4.
  • this product ig to the effect of acetic acid-induced peritoneal exudation test 78 mice, weighing 18-22g, both, randomly divided into 6 groups, high, medium and low dose groups respectively according to 10ml / kg ( Use this product's 2 concentrating solution 5ml), 5ml /kg, 2. 5 ml/kg to give this product, the positive control group and the ethanol control group respectively give Fengjiu medicinal liquor 10ml/kg (spent part of ethanol, See material item) and 27% ethanol; blank control group for water supply. The administration volume was 10 ml/kg, and continuous ig administration was carried out for 4 days.
  • mice 30 min after the last administration, each mouse was injected with 0.5% Evans blue 5 ml/kg, followed by ipO. 7% acetic acid 10 ml/kg, 30 min after ig vinegar weight, the mice were sacrificed by pulling the neck, and the amount of normal saline was used. Rinse the abdominal cavity, collect all the washing liquid and add the weight of saline to 10ml/kg. After centrifugation, take the supernatant and measure the DD value at 578mm. The DD value indicates the content of Evans blue in the washing liquid, indirectly, reflecting the peritoneal inflammation exudation. Degree. Compared with the ethanol level, an inter-group t-test was performed. The results are shown in Table 5. Table 5. Results of infiltration of peritoneal inflammation in mice induced by acetic acid
  • the blank group 10 10 0.244 ⁇ 0.044 The results showed that the D values of the high, medium and low dose groups of the product were similar to those of the ethanol group and the blank group, and the difference was not significant. The difference between the von group and the low group was very significant (P ⁇ Q. Gl. It is suggested that this product ig administration has no inhibitory effect on peritoneal inflammation exudation induced by acetic acid in mice.
  • mice Take 72 mice, weighing 24-26g, ? ⁇ is used in combination and is randomly divided into 5 groups. Each mouse was anesthetized with sodium pentobarbital, and the sterilized dry cotton ball was embedded under the aseptic operation to the right side of the back, about 2.5 cm from the surgical incision. The next day after the operation, the surface of the cotton ball was depilated 2 X 2cm 2 , apply the liquid to the skin of the hair removal area. The high and low doses are given according to 20ml /kg (10ml of concentrated solution of this product) and 5ral/kg respectively.
  • mice were taken, weighing 22-24 g, and $ ⁇ was used together and randomly divided into 6 groups.
  • Each mouse was anesthetized with sodium pentobarbital, and the sterile dry cotton ball (20 mg) was immersed in the right side of the back under the aseptic operation, about 2. 5 cm from the surgical incision.
  • each group was 10 ml/kg (partial ethanol was removed, see material item); ethanol group was given 27% ethanol; blank control group was given water.
  • the dosage volume of each group was 10 ml/kg, igl times per day for 7 consecutive days.
  • the mice were sacrificed by necking, and the cotton granuloma was taken out and placed in an oven at 60 ° C for 16 hours, then accurately weighed, minus the original dry cotton ball (20 ml / only). Swelling, compared with the blank group, for t-test between groups. The results are shown in Table 7.
  • Blank group 12 10 27. 5 + 8. 7* The results showed that the granuloma weights in the high, medium and low dose groups were 21. 4%, 20.5%, 28. 2% lower than those in the blank group, respectively. The inhibition rates of the three groups were close, and the difference in the low dose group was significant. It suggests that the ig administration of this product may have a certain inhibitory effect on the proliferation of subcutaneous cotton granuloma in mice.
  • mice with a pain threshold of 10-20 seconds were selected, and the total weight was 20-24 g, which were randomly divided into 5 groups.
  • the pain was measured by the hot plate method: the mice were placed in an iron box with a bottom plate temperature of 55 ⁇ 0.5 ° C, and the time from the time when the mouse was put into the iron box to the time when the foot was added was used as the pain threshold.
  • the high, medium and low dose groups were respectively treated with 16 ml/kg of this product 2 times concentrated solution), 8 ml/kg, 5 ml/kg to the base of the product;
  • the medicinal liquor 8ml/kg was coated with double soles; the blank group was coated with water; both groups were coated with 8ml/kg.
  • the pain thresholds of each rat were measured at 30 min, 60 min, and 90 min after drug application.
  • the post-dose pain threshold was compared with the blank group for t-test. The results are shown in Table 8.
  • mice weighing 22-25 g, were randomly divided into 5 groups.
  • the pain was measured by the hot plate method: the mice were placed in an iron box with a bottom plate temperature of 55 ⁇ 0.5 ° C, and the time from the time when the mouse was put into the addition of the hind foot was used as the pain threshold.
  • 30mim after the pre-dose pain threshold was measured, and the high, medium and low dose groups were given 10ml/kg (5ml of pesticide solution 2 times), 5ml/kg, 2.5ml/kg, respectively; Sexual medicinal liquor 10ml/kg (spent part of ethanol, see material item); blank control group water supply; ethanol group gave 27% ethanol.
  • Each group of ig administration volume was 10 ml/kg.
  • the pain thresholds of each rat were measured at 30 mim, 60 mim, and 90 mim after administration, and the post-dose pain threshold was compared with the blank group for t-test. The results are shown in Table 9.
  • mice Take 60 mice, weighing 22-25g, ? Each half is divided into 6 groups.
  • the high, medium and low dose groups were given 10 ml/kg (5 ml concentrated solution of this product, 5 ml/kg, 2. 5 ml/kg), and the positive control group was given 10 ml/kg of Fengjiu medicinal liquor ( Part of the ethanol was removed, see material item); blank control group was given water; ethanol group was given 27% ethanol. All were administered by ig, and the administration volume was 10 ml/kg.
  • mice Effect of external application on the repair of soft tissue contusion in mice. Take ⁇ mice and weigh 29-33g. Soft tissue contusion after depilation of the right hind leg of each mouse: Place the right hind leg of the mouse on the rubber pad, paste the rootstock on the corresponding part of the hind leg, use the 500g method to freely fall from the height of 14cm, and shoot the rootstock. The muscles of the rats are pressed, causing soft tissue contusion in the right hind leg of the mouse, and the skin is damaged. After modeling, the rats were randomly divided into 5 groups according to the injury, and then administered immediately: 10 ml of the product in the high, medium and low dose groups (5 ml of the concentrated solution of this product), 5 ml/kg, 2.
  • the positive control group and the ethanol control group were given Fengjiu medicinal liquor and 55% ethanol in 10 ml/kg, respectively. Divided twice a day, the dosage volume was 10ml/kg, and the drug was continuously administered for 7 days. Each mouse was scored every day from the 3rd day of administration (see Table 11-1 for the scoring criteria), and the scores of each group were compared with the ethanol group for t-test between groups. The results are shown in Table 11-2. Four hours after the last administration, the mice were sacrificed, and the skin of the right hind leg was removed, and the soft tissue contusion repair was observed. The results are shown in Table 11-3 and attached photos. Table 11-1, Contusion Repair Scoring Criteria
  • Escherichia coli, Staphylococcus aureus, and Streptococcus mutans were placed in the corresponding medium, and cultured at 36 ° C for 24 hours for testing.
  • Control 1 2. 5 1: 5 1: 10 1: 20 1: 40 1: 80 1: 160 1: 320 E. coli + ⁇ - + + + + + + Staphylococcus aureus + - - + + + + + + Streptococcus B + - - + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
  • the results show that: the local application of this product has a significant expansion effect on the auricle capillaries of mice, and has a certain promoting effect on the absorption of blood spots under the ears of rabbits.
  • the topical application of the product and ig administration have a certain inhibitory effect on the swelling of the mouse ear caused by croton oil, and also have a certain inhibitory effect on the proliferation of the subcutaneous cotton granuloma in mice; , no significant effect on the peritonitis inflammatory exudation induced by acetic acid in mice.
  • the topical application of this product and ig administration have certain analgesic effects on the pain caused by hot plate in mice.
  • the topical application of this product has a certain promoting effect on the repair of soft tissue damage in mice.
  • the in vitro antibacterial test results showed that the minimum inhibitory concentration of this product on E. coli was 1:10, and that of Staphylococcus aureus and Streptococcus mutans was 1:20.
  • the above-mentioned effects of promoting blood circulation, eliminating inflammation, relieving analgesia, antibacterial, and promoting soft tissue damage provide a certain animal test basis for clinical application of this product.
  • the summary report of the clinical report of the treatment of acute contusion and rickets in the treatment of acute swelling and pain relief of the present invention From May to July 1994, the First affiliated Hospital of Guangxi College of Traditional Chinese Medicine, the Second affiliated Hospital, and the Guangxi People's Hospital adopted a randomized and controlled method. 324 patients with acute contusion and rickets (175 patients in the control group) were clinically validated. The results showed that Xiaozhongzhitongjing has the effects of reducing swelling and relieving pain, relaxing the muscles and promoting blood circulation and removing blood stasis. The total effective rate of this group in the treatment of acute contusion and rickets was 93.3% and 92.6%, respectively. The curative effect was not significantly different from that produced by Yulin Pharmaceutical Factory. This product has no obvious toxic and side effects. Individual patients may develop contact dermatitis for external use, and may have nausea symptoms when taken orally.
  • the subjects included were all patients with acute contusion within 3 days of the disease and those who met the diagnostic criteria of Chinese medicine for diagnosis of phlegm and blood stasis.
  • 324 patients were treated with Xiaozhongzhitongjing.
  • 175 cases were treated with Yunxiangjing produced by Guangxi Yulin Pharmaceutical Factory. There were no significant differences in gender and age distribution between the two groups, as shown in Table 1.
  • Sprains are indirect violence that causes the joint to undergo a torsion that exceeds normal limits, causing partial tearing of the ligaments, tendons, and joints attached to the joints. Often occurs in the ankle, knuckles and lumbar push, manifested as local pain, swelling, ecchymosis and joint movement disorders.
  • Contusion is the damage of subcutaneous tissue and muscle caused by blunt object impact or collision. It is characterized by pain, swelling, bruising of the skin, hematoma and tenderness. In severe cases, there are fascia, muscle fiber tears or deep hematoma.
  • the type of syndrome of cold and dampness obstruction in rickets is selected as the object of observation.
  • the syndrome criteria are as follows: limb joints are cold and painful, or swollen, local chills, skin color is not red, touch is not hot, cold and pain increase, The heat is reduced, the tongue is fat, the quality is light, the moss is greasy or white, and the pulse string is tight or the string is slow.
  • This verification determines the diagnostic criteria, inclusion criteria, exclusion criteria, case grouping, usage and dosage of the two groups of drugs, observation items and methods, efficacy criteria, adverse reaction observations, and statistical treatment methods for qualified subjects.
  • Dosage treatment and administration method (1) Treatment group and open treatment group: 100 cases were treated with swelling and painkilling, and the drug solution was applied to the affected area, sputum, 6 times per sputum.
  • Control group 30 cases, using painful swelling [produced by Guangxi Longzhou Pharmaceutical Factory, Guiwei Medicine Zhunzi (1982) No. 04101], applying the liquid to the affected area, sputum, rickets daily 3 Times, acute contusion, 6 times per sputum.
  • Grade data is analyzed by Ridit, count data is analyzed by X 2 , and measurement data is checked by t (u).
  • Control group 30 12 8 4 3 3 Open group 50 7 20 10 10 3
  • the treatment group was compared with the control group, X 2 1.39, P> 0.05, no significant difference.
  • the total score of the acute contusion treatment group and the control group before treatment, U 1.80, ⁇ > 0.05, The difference was not significant.
  • the above pre-treatment comparison showed that there was no significant difference between the two groups in terms of gender, age, disease type, disease course, and pre-treatment condition. It is suggested that the main factors affecting the prognosis of the two groups are balanced.
  • Urine routine 67 cases were detected before treatment, and 67 cases in the normal range were reviewed after treatment. No abnormalities were found.
  • Electrocardiogram 67 cases were detected before treatment, and 67 cases were reviewed after treatment in the normal range. No abnormalities were found.
  • ALT 67 cases were detected before treatment, of which 67 cases were treated after the normal range, No abnormalities.
  • BCr 67 cases were detected before treatment, and 67 cases were reviewed after treatment in the normal range. No abnormalities were found.
  • BUN 67 cases were detected before treatment, and 67 cases were reviewed after treatment in the normal range. No abnormalities were found.
  • Urine routine 20 cases were detected before treatment, and 20 cases were reviewed after treatment in the normal range. No abnormalities were found.
  • Electrocardiogram 73 cases were detected before treatment, and 73 cases in the normal range were reviewed after treatment. No abnormalities were found.
  • ALT 20 cases detected before treatment, wherein the treatment of the normal range after review of 20 patients were normal.
  • BUN before treatment examined 20 cases, 20 cases of normal after treatment range review, were normal.

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention provides a Traditional Chinese Medicament for treating injuries from falls, rheumatism and ostealgia and method for manufacture thereof. The present medicament is manufactured from 21 TCM materials, such as Radices saussureae, Radices sileris, Herba schizeneptae, Herba asari, Cortex acanthopanacis, Ramulus, Radix achyranthis, Rhizoma ligustici, etc. Zoological studies and clinical trials indicate that the present medicament is capable of being effective in relieving arthralgia caused by rheumatism, periomitis, injuries from falls, such as acute sprain and contusion, anonymous intumescence, parotitis.

Description

一种治疗跌打损伤、 风湿骨痛的中药制剂及其制备方法 技术领域  Traditional Chinese medicine preparation for treating bruises and rheumatic bone pain and preparation method thereof
本发明涉及含中草药活性成分的医药配制品, 具体而言, 涉及一种治 疗跌打损伤、 风湿骨痛的中药制剂及其制备方法。 背景技术  The invention relates to a pharmaceutical preparation containing an active ingredient of a Chinese herbal medicine, in particular to a traditional Chinese medicine preparation for treating bruises and rheumatic bone pain and a preparation method thereof. Background technique
才艮据 《我国风湿四病流行病学抽样调查》, 风湿病在中国的自然人群 发病率为 14%, 特种行业 (纺织、 钢铁机械、 化工、 矿山石油、 港口、 军 队) 高达 23. 1%; 风湿四病主要患病人群在 40 ~ 60岁; 目前我国估计有 1. 82 亿人患风湿病, 40岁以上患者占到 9464万人。 风湿病给患者造成在日常生 活和工作的行动不便, 而且致残率高, 对患者本人的生理、 心理造成极大 影响, 给社会形成极大的负担。 虽然目前临床上有许多治疗跌打损伤、 风 湿骨痛的中药制剂, 但临床效果都不甚理想, 且有一定的不适感和副作用。 发明内容  According to the "Study on the Epidemiological Survey of Rheumatism in China", the incidence rate of natural diseases of rheumatism in China is 14%, and the special industry (textile, steel machinery, chemical industry, mining oil, port, army) is as high as 23.1%. The main patient population of rheumatism is 40 to 60 years old; at present, there are an estimated 182 million people suffering from rheumatism in China, and 94.46 million people over 40 years old. Rheumatism causes inconvenience to the patient in daily life and work, and the disability rate is high, which has a great impact on the patient's own physiology and psychology, and imposes a great burden on the society. Although there are many traditional Chinese medicine preparations for treating bruises and rheumatism and bone pain, the clinical effects are not satisfactory, and there are certain discomforts and side effects. Summary of the invention
本发明的目的在于提供一种疗效显著、 作用迅速、 副作用小的治疗跌 打损伤、 风湿骨痛的中药制剂。  The object of the present invention is to provide a traditional Chinese medicine preparation which has remarkable curative effect, rapid action and small side effects for treating bruises and rheumatism.
本发明的另一目的是提供上述中药制剂的制备方法。  Another object of the present invention is to provide a process for the preparation of the above-mentioned traditional Chinese medicine preparation.
本发明的技术方案如下:  The technical solution of the present invention is as follows:
风湿骨痛大多由于风寒湿邪侵袭人体, 闭阻经络, 气血运行不畅所致, 而跌打损伤可致瘀血痹阻经络, 这两种情形在临床上通常导致以肌肉、 筋 骨、 关节发生酸痛、 麻木、 重着、 肿胀、 屈伸不利等症状, 因此, 本发明 人根据 "通则不痛、 痛则不通" 的中医理论, 针对上迷疾病的病因机理, 制定了 "消肿止痛、 活血化瘀、 驱风通络、 祛寒化湿" 的治疗原则, 筛选 出本发明的組方, 由此制备的中药制剂对跌打损伤、 风湿骨痛具有显著的 疗效, 在临床上可适用于例如风寒湿痹、 肩周炎、 急性扭挫伤、 无名肿毒、 腮、腺肿痛等疾病。 Most of the rheumatism and bone pain is caused by wind, cold and dampness invading the human body, blocking the meridians, and the blood and blood are not running smoothly. The bruises can cause blood stasis and obstruction of the meridians. These two conditions usually lead to muscles, bones and joints in the clinic. Symptoms such as soreness, numbness, heavyness, swelling, and poor flexion and extension, etc., therefore, the present invention According to the theory of traditional Chinese medicine that "the general rule is not painful, the pain is not feasible", according to the etiological mechanism of the disease, the principle of "reducing swelling and relieving pain, promoting blood circulation to remove blood, relieving wind and collaterals, and phlegm and phlegm and dampness" has been formulated. The preparation of the traditional Chinese medicine preparation prepared by the invention has remarkable curative effect on bruises and rheumatoid bone pain, and is clinically applicable to, for example, wind-cold dampness, frozen shoulder, acute contusion, anonymous swollen poison, sputum, Glandular swelling and other diseases.
除另有说明除外, 本发明提供的药物原料药均是以重量份计。  Unless otherwise stated, the pharmaceutical drug substances provided by the present invention are all in parts by weight.
本发明一种治疗跌打损伤、 风湿骨痛的中药制剂的方案为:  The invention provides a Chinese medicine preparation for treating bruises and rheumatic bone pain as follows:
防风 30-80 荆芥 30-80 细辛 30-80  Windproof 30-80 Nepeta 30-80 Asarum 30-80
膝 30-80 川芎 30-80 徐长卿 30- 80 莪术 30-80 大罗伞 85-120 小罗伞 55-90 两面针 85- 120 三棱 55-90。  Knee 30-80 Chuanxi 30-80 Xu Changqing 30-80 Qishu 30-80 Da Luo Umbrella 85-120 Ronaldinho 55-90 Double-sided needle 85- 120 Triangular 55-90.
本发明一种治疗跌打损伤、 风湿骨痛的中药制剂的优选方案为: 防风 30-80 荆芥 30-80 细辛 30-80  The preferred scheme of the traditional Chinese medicine preparation for treating bruises and rheumatic bone pain is as follows: windproof 30-80 Nepeta 30-80 Asarum 30-80
牛膝 30-80 川芎 30 - 80 徐长卿 30-80 莪术 30 - 80 大罗伞 85-120 小罗伞 55-90 两面针 85- 120 三棱 55-90 樟脑 40-90 薄荷脑 40-90。  Achyranthes 30-80 Chuanxiong 30 - 80 Xu Changqing 30-80 莪 30 30 - 80 大罗伞 85-120 小罗伞 55-90 Two-sided needle 85- 120 三棱 55-90 Camphor 40-90 Menthol 40-90.
本发明一种治疗跌打损伤、 风湿骨痛的中药制剂的另一优选方案为: 防风 30-80 荆芥 30-80 细辛 30-80  Another preferred embodiment of the traditional Chinese medicine preparation for treating bruises and rheumatic bone pain according to the present invention is: Windproof 30-80 Nepeta 30-80 Asarum 30-80
牛膝 30-80 川芎 30-80 徐长卿 30-80 莪术 30- 80 大罗伞 85-120 小罗伞 55-90 两面针 85- 120 三棱 55- 90 樟脑 40-90 薄荷脑 40-90 桂枝 30-80 白芷 30-80 红杜仲 55 - 90。 Achyranthes 30-80 Chuanxiong 30-80 Xu Changqing 30-80 Qishu 30-80 Da Luo Umbrella 85-120 Ronaldo Umbrella 55-90 Double-sided needle 85- 120 Triangular 55- 90 Camphor 40-90 Menthol 40-90 Guizhi 30-80 白芷30-80 Red Eucommia 55-90.
本发明一种治疗跌打损伤、 风湿骨痛的中药制剂的再一优选方案为: 防风 30-80 荆芥 30-80 细辛 30-80 牛膝 30-80 川芎 30 - 80 徐长卿 30-80 莪术 30-80 大罗伞 85-120 小罗伞 55-90 两面针 85- 120 三棱 55-90 樟脑 40-90 薄荷脑 40-90 桂枝 30-80 白芷 30-80 红杜仲 55-90 木香 30-80 五加皮 30-80 黄藤 80-105 栀子 85-120。  A further preferred embodiment of the traditional Chinese medicine preparation for treating bruises and rheumatic bone pain according to the present invention is: windproof 30-80 Nepeta 30-80 Asarum 30-80 Achyranthes 30-80 Chuanxi 30-80 Xu Changqing 30-80 30-80 大罗伞85-120 小罗伞55-90 两面针85- 120 三棱55-90 camphor 40-90 menthol 40-90 桂枝30-80 白芷30-80 红杜仲55-90 木香30-80 Wujiapi 30-80 Huangteng 80-105 Scorpion 85-120.
本发明一种治疗跌打损伤、 风湿骨痛的中药制剂的最优选方案为 防风 30-80 荆芥 30- 80 细辛 30-80 牛膝 30-80 川芎 30-80 徐长卿 30-80 莪术 30-80 大罗伞 85-120 小罗伞 55-90 两面针 85-120 三棱 55-90 樟脑 40-90 薄荷脑 40-90 桂枝 30-80 白芷 30 - 80 红杜仲 55-90 木香 30-80 五加皮 30-80 黄藤 8G-105 栀子 85-120 沉香 20-40。  The most preferable scheme of the traditional Chinese medicine preparation for treating bruises and rheumatic bone pain is the windproof 30-80 Nepeta 30-80 Asarum 30-80 Achyranthes 30-80 Chuanxi 30-80 Xu Changqing 30-80 Qishu 30- 80 大罗伞85-120 小罗伞55-90 Double-sided needle 85-120 三棱55-90 Camphor 40-90 Menthol 40-90 Guizhi 30-80 白芷30 - 80 红杜仲55-90 木香30- 80 five plus skin 30-80 yellow rattan 8G-105 scorpion 85-120 agarwood 20-40.
本发明的中药制剂可以是采用本领域常规的制剂工艺制备的药剂学上 可接受的任意剂型。 优选酊剂、 水剂、 乳剂等。  The traditional Chinese medicine preparation of the present invention may be any pharmaceutically acceptable dosage form prepared by a conventional formulation process in the art. An expectorant, a liquid, an emulsion or the like is preferred.
本发明中, 上述原料药的优选用量配比为:  In the present invention, the preferred ratio of the above-mentioned drug substance is:
木香 70 防风 60 荆芥 70  Woody 70 windproof 60 Nepeta 70
细辛 70 五加皮 60 桂枝 50  Asarum 70 Wujiapi 60 Guizhi 50
牛膝 70 川芎 50 徐长卿 40 白芷 70 莪术 60 红杜仲 70 Achyranthes 70 Sichuan Chuan 50 Xu Changqing 40 白芷70 莪术60 红杜仲70
大罗伞 110 小罗伞 60 两面针 100  Big Luo umbrella 110 small Luo umbrella 60 double needle 100
黄藤 85 栀子 90 三棱 85  Yellow vine 85 栀子 90 三棱 85
沉香 25 樟脑 80 薄荷脑 50  Agarwood 25 camphor 80 menthol 50
本发明中, 上述原料药的用量配比还优选:  In the present invention, the amount ratio of the above-mentioned drug substance is also preferably:
木香 47 防风 47 荆芥 47  Woody 47 windproof 47 Nepeta 47
细辛 47 五加皮 47 桂枝 47  Asahi 47 Wujiapi 47 Guizhi 47
牛膝 47 川芎 47 徐长卿 47  Achyranthes 47 Chuanxi 47 Xu Changqing 47
¾芷 70 莪术 47 红杜仲 70  3⁄4芷 70 莪 47 47 Red Eucommia 70
大罗伞 100 小罗伞 70 两面针 100  Big Luo umbrella 100 small Luo umbrella 70 double needle 100
黄藤 80 栀子 1GQ 三棱 70  Yellow vine 80 scorpion 1GQ three-sided 70
沉香 32. 5 樟脑 55 薄荷脑 55  Agarwood 32. 5 camphor 55 menthol 55
本发明中, 上述原料药的优选用量配比为:  In the present invention, the preferred ratio of the above-mentioned drug substance is:
木香 35 防风 60 荆芥 35  Woody 35 windproof 60 Nepeta 35
细辛 40 五加皮 80 桂枝 40  Asahi 40 Wujipi 80 Guizhi 40
牛膝 40 川芎 50 徐长卿 40  Achyranthes 40 Chuanxiong 50 Xu Changqing 40
白芷 35 莪术 50 红杜仲 80  White 芷 35 莪 50 50 Red Eucommia 80
大罗伞 110 小罗伞 80 两面针 90  Big Luo umbrella 110 small Luo umbrella 80 double needle 90
黄藤 95 栀子 110 三棱 80  Yellow rattan 95 scorpion 110 triangular 80
沉香 40 樟脑 4G 薄荷脑 80  Agarwood 40 camphor 4G menthol 80
本发明中药酊剂可按如下制备工艺进行制备: The traditional Chinese medicine tanning agent can be prepared according to the following preparation process:
将以上除樟脑、 薄荷脑外的其余木香等原料药粉碎成粗粉, 依照制备 流浸膏剂与浸膏剂的渗漉法(参见中国药典 2000 年版一部附录 10 ), 用 7000 ~ 8000重量份的 50-95 %乙醇作溶剂, 浸渍 15- 30小时后, 以每分钟 约 1-10 ml的速度緩緩渗漉,收集漉液,另器保存;取樟脑、薄荷脑加 500 ~ 800重量份的 50-95 %乙醇使溶解后, 与上述漉液混匀, 静置 20-72小时, 滤过, 即得。 The above raw materials such as camphor and menthol are pulverized into coarse powder according to the method of preparing a liquid extracting agent and an extracting agent (see Appendix 10 of the Chinese Pharmacopoeia 2000 edition). 7000 ~ 8000 parts by weight of 50-95% ethanol as solvent, after immersion for 15-30 hours, slowly ooze at a rate of about 1-10 ml per minute, collect sputum, and store it; take camphor, menthol plus After 500-800 parts by weight of 50-95% ethanol is dissolved, it is mixed with the above-mentioned mash, allowed to stand for 20-72 hours, and filtered to obtain.
本发明中药制剂的用法与用量: 外用, 擦患处。 口服, 必要时饭前服 用, 一次 5 ~ 10ml , —日 1 ~ 2次。 注意: 孕妇忌服; 外用时不宜擦腹部。 密封贮藏, 并置阴凉处。  Usage and dosage of traditional Chinese medicine preparation of the invention: external use, rubbing the affected area. Oral, if necessary, before meals, 5 ~ 10ml, - 1 ~ 2 times a day. Note: Pregnant women should not take it; it should not be rubbed when used externally. Store in a sealed place and place in a cool place.
本发明的原料药的主要活性成分及其作用如下: 木香, 其中的云木香 才艮含挥发油 0. '3 ~ 3%, 其中成分为单紫杉烯、 α -罗兰酮、 β -芹子烯、 风 毛菊内酯、 木香浠内酯、 木香酸、 木香醇、 α -木香烃、 β -木香烃、 木香 内酯、 莰烯、 水芹烯、 脱氢木香内酯、 二氢脱氢木香内酯等。 此外, 根尚 含甾醇、 白桦脂醇、 树脂、 菊糖及木香碱等。 其药理作用为: ①解痉及降 压作用, ②抗菌作用。 功能主治包括 行气止痛, 温中和胃。 治疗中寒气 滞, 胸腹胀痛, 呕吐, 泄泻, 下痢里急后重, 寒疝。 防风, 含挥发油、 甘 露醇、 苦味甙等。 其药理作用为: ①解热作用, ②镇痛作用, ③抗菌作用。 功能主治为发表, 祛风, 胜湿, 止痛。 治外感风寒, 头痛, 目眩, 项强, 风寒湿痹, 骨节酸痛, 四肢挛急, 破伤风。 荆芥, 含挥发油 1. 8%, 油中主 成分为右旋薄荷酮、 消旋薄荷酮、 少量右旋柠檬烯。 其药理作用为: 用人 工发热的家兔, 口服荆芥箭剂与浸膏 2克(生药) /公斤, 无甚解热作用。 在体外, 高浓度(1: 100 )有抗结核杆菌之作用。 功能主治为发表, 祛风, 理血; 炒炭止血。 治感冒发热, 头痛, 咽喉肿痛, 中风口噤, 吐血, 衄血、 便血; 崩漏, 产后血晕; 痈肿, 疮疥、 瘰疬。 荆芥穗效用相同, 惟发散之 力较强。 细辛, 辽细辛含挥发油约 , 挥发油的主要成分是曱基丁香油酚, 其他有黄樟醚、 β -蒎烯,、优葛缕酮、酚性物质等; 华细辛含挥发油 2. 75%, 1. 9%。 挥发油中主要含曱基丁香油酚(约占 50°/。), 还有细辛酮、 蒎烯、 优 葛缕酮、 黄樟醚、 1, 8-按叶素、 I -细辛素 (约 0. 2% )等。 华细辛的变种 和挥发油的成分和华细心相似; 双叶细辛的挥发油含优葛缕酮 6%、 龙脑或 爱草脑 7%、 1, 8-桉叶素 4% 、 麟 2%、 甲基丁香油酚 15%、 黄樟醚 10%、 科绕魏素 10%、 榄香脂素 8%、 少辛酮 0. 2%、 芳樟醇、 大 牛儿三烯醇、 2- 甲基 -2-乙烯基 -3-异丙烯基 -5-异丙叉环己醇等; 圆叶细辛全草含黄酮甙、 氨基酸、 糖类和挥发油。 其药理作用为: ①局部麻醉作用, ②解热、 镇痛 作用, ③抑菌作用, ④对血压的作用。 功能主治: 祛风, 散寒, 行水, 开 窍。 治风冷头痛, 鼻渊, 齿痛, 痰饮咳逆, 风湿痹痛。 五加皮, 五加的根 皮含挥发油 (为 4-甲基水杨醛等)、 鞣质、 棕榈酸、 亚麻酸以及维生素 Α、 Bl D 无梗五加的根含芝麻素、 洒维宁、 丁香树脂酚的单葡萄糖甙(五加甙 B )和汉葡萄糖甙(五加甙 D )等木脂体成分, 还含胡萝卜 醇、 强心甙和 皂甙等。 此外, 还含水溶性多糖如聚葡糖和碱溶性多糖, 后者水解产生半 乳糖醛酸、 葡萄糖、 阿拉伯糖、 鼠李糖和木糖等。 刺五加的根含多种糖甙, 其中有胡萝卜甾醇、 7-羟基- 6, 8-二曱氧基香豆精 ct -葡萄糖甙、 乙基 α - 半乳糖甙、丁香树脂酚葡萄糖甙、丁香甙等。此外,尚含芝麻素、多糖( 2. 3 ~ 5. 7°/。)。 茎含糖武 0. 6 ~ 1. 5%)。 果实含水溶性多糖 17 ~ 20%, 其中含果胶物 盾。 其药理作用为: 1.无梗五加的药理作用 ①抗炎作用, ②镇痛、 解热 作用, ③对心血管的影响; 刺五加的药理作用, 刺五加具有较人参更好 的 "适应原,, 样作用。 功能主治: 祛风湿, 壮筋骨, 活血去瘀。 治风寒湿 痹, 筋骨挛急, 腰痛, 阳痿, 脚弱, 小儿行迟, 水肿, 脚气, 疮疽肿痛, 跌打劳伤。 桂枝, 其药理作用为: ①抗菌作用, ②抗病毒作用, ③利尿作 用。 功能主治为: 发汗解肌, 温经通脉。 治风寒表证, 肩背肢节酸痛, 胸 痹痰饮。 牛膝, 其根含三萜皂甙, 水解后生成齐墩果酸, 并含多量钾盐。 种子中也含三萜皂甙, 与根所含的相同。 另含有蜕皮甾酮, 和因考甾酮。 其药理作用为: ①对子宫的作用, ②对肠管的作用, ③对心血管系统的作 用, ④止痛作用。 功能主治为: 生用散瘀血, 消痈肿。 治淋病, 尿血, 经闭, 症瘕, 难产, 胞衣不下, 产后瘀血腹痛, 喉痹, 痈肿, 跌打损伤。 熟用补肝肾, 强筋骨。 治腰膝骨痛, 痿痹。 川芎, 其根含挥发油、 生物 碱、 酚性成分、 内酯类、 阿魏酸。 其药理作用为: ①对中枢神经系统的作 用, ②降压作用, ③对平滑肌的作用, ④抗菌作用等。 功能与主治: 活血 行气, 祛风止痛。 用于月经不调, 经闭痛经, 症瘕腹痛, 胸胁刺痛, 跌朴 肿痛, 头痛, 风湿痹痛。 徐长卿, 全草含牡丹酚约 1°/», 又找出又与肉珊瑚 甙元、 去酰牛皮消甙元、 茸毛牛奶藤甙元和去酰萝摩甙元极为相似的物质 以及醋酸、 桂皮酸等。 根含黄酮甙、 糖类、 氨基酸、 牡丹酚。 功能与主治: 祛风化湿, 止痛止痒。 用于风湿痹痛, 胃痛胀满, 牙痛, 腰痛, 跌朴损伤; 荨麻疹, 湿疹。 白芷, 白芷全草含挥发油, 四川省遂宁产白芷根含黄色挥 发油 0. 24%。 杭白芷根含六种呋喃香豆精: 异欧芹属素乙、 异欧芹属素乙、 佛手柑内酯、 珊瑚菜素、 氧化前胡素、 水化氧化前胡素等。 其药理作用为: 抗菌作用。 功能与主治: 散风除湿, 通窍止痛, 消肿排脓。 用于感冒头痛, 眉棱骨痛, 鼻塞, 鼻渊, 牙痛, 白带, 疮疡肿痛。 莪术, 功能与主治: 行 气破血, 消积止痛。 用于症瘕痞块, 瘀血经闭, 食积胀痛; 早期宫颈癌。 红杜仲, 来源: 本品为夹竹^ >科植物红杜仲藤 Parabarium chunianum Ts iang、 毛杜仲藤 Parabarium huait ingi i Chun et Tsiang , 杜仲藤 Parabarium micranthun (A. DC. ) Pierre或花皮胶藤 Ecdysanthera ut il i s Hay. et Kaw. 的干燥树皮, 功能与主治: 祛风活络, 壮腰膝, 强筋骨, 消肿。 用于小儿麻痹, 风湿骨痛, 跌打损伤。 大罗伞, 来源: 豆科植物疏 叶崖豆藜 Mi l lettia pulchra ( Colebr. ) Kurz forma laxior Dunn.的干燥 根。 小罗伞, 来源: 紫金牛科植物朱砂根 Ardis ia crenata Sims.的干燥 根。 功能与主治: 活血调经, 祛风除湿。 治经闭、 痛经, 风湿痹痛、 跌打 损伤。 两面针, 功能与主治: 行气止痛, 活血化瘀, 祛风通络。 用于气滞 血瘀引起的跌朴损伤、 风湿痹痛、 胃痛、 牙痛, 毒蛇咬伤; 外治汤火烫伤。 作用与用途: 本品为笨并菲啶类生物碱。 对 P388 和 L1210 白血病小鼠有 较好的生命延长率, 对艾氏腹水癌小鼠的生命延长率可达' 250 % , 、鼠 白血病模型 AL771的生命延长率为 150 %左右。 对 HeLa细胞在 1微克 /毫 升时有明显的细胞毒作用。 可提取两面针类生物碱, 如两面针碱 26 和氯 化两面针碱 27。 黄藤, 功能与主治: 清热解毒。 用于妇科炎症, 外科感染, 菌痢, 肠炎, 呼吸道及泌尿道感染, Θ艮结膜炎。 黄藤的根含掌叶防己碱、 药根减、 非洲防己碱、 黄藤素曱、 黄藤素乙、 黄藤内酯、 甾醇。 栀子, 功 能与主治: 泻火除烦, 清热利尿, 凉血解毒。 用于热病心烦, 黄疸尿赤, 血淋涩痛, 血热吐衄, 目赤肿痛, 火毒疮疡; 外治扭挫伤痛。 三棱, 小黑 三棱含挥发油 0. 05%。 功能与主治: 破血行气, 消积止痛。 用于症瘕痞块, 瘀血经闭, 食积胀痛。 沉香, 含沉香螺旋醇、 a-沉香呋喃、 B-沉香呋喃、 二氢沉香呋喃、 去甲沉香呋喃酮、 4-羟基二氢沉香呋喃、 3, 4-二羟基二氢 沉香呋喃、 沉香醇; 功能与主治: 行气止痛, 温中止呕, 纳气平喘。 用于 胸腹胀闷疼痛, 胃寒呕吐呃逆, 肾虚气逆喘急。 The main active ingredient of the drug substance of the present invention and the action thereof are as follows: woody, wherein the Yunmuxiangcai contains volatile oil 0. '3 ~ 3%, wherein the components are single taxane, α-Rolandone, β-celery Isoene, scutellarin, citronella, eucaly, woody acid, woody alcohol, alpha-woody hydrocarbon, beta-woody hydrocarbon, woody lactone, decene, water phlegm, dehydrogenated woody Lactone, dihydrodehydroxylactone, and the like. In addition, the roots also contain sterol, betulin, resin, inulin and eucalyptus. Its pharmacological effects are: 1 antispasmodic and antihypertensive effects, 2 antibacterial effects. Indications include qi and pain relief, warm stomach and stomach. Treatment of cold qi stagnation, chest and abdomen pain, vomiting, diarrhea, squatting in the squat, heavy, cold. Windproof, containing volatile oil, mannitol, bitter miso, etc. Its pharmacological effects are: 1 antipyretic effect, 2 analgesic effect, 3 antibacterial effect. The main function of the function is to publish, hurricane, win the wet, and relieve pain. Exogenous cold, headache, dizziness, strong, cold and dampness, sore throat, limbs urgency, tetanus. Nepeta, containing volatile oil 1.8%, the main component of the oil is dextrin, racemic menthone, a small amount of d-limonene. Its pharmacological effects are: artificially heated rabbits, oral schisandra and 2 grams of extract (raw drug) / kg, no heat. In vitro, high concentrations (1: 100) have the effect of anti-tuberculosis. The main function of the function is to publish, hurricane, and blood; Treatment of cold fever, headache, sore throat, stroke sputum, vomiting blood, blood stasis, blood in the stool; uterine bleeding, postpartum blood halo; bloated, sore, phlegm. The effect of schisandra chinensis is the same, but the strength of scatter is stronger. Asarum, Liao Xixin contains volatile oil, the main component of volatile oil is decyl eugenol, Others include xanthine, β-pinene, eucalyptone, phenolic substances, etc.; Hua Xixin contains volatile oil 2.75%, 1.9%. Volatile oil mainly contains decyl eugenol (about 50 ° /.), as well as asarone, terpene, eucalyptone, xanthine, 1, 8-alpha, I-asarone (about 0 . 2% ) and so on. The variation of Huaxinxin and the composition of volatile oil are similar to those of Huaxin; the volatile oil of Asarum sinensis contains 6% of eucalyptone, 8% of borneol or lycopene, 4% of eucalyptus 4%, and 2% of lin. , methyl eugenol 15%, xanthine 10%, ketone 10%, eucalyptus 8%, less octyl ketone 0.2%, linalool, big cattle trienol, 2-methyl- 2-vinyl-3-isopropenyl-5-isopropylidenecyclohexanol; etc.; Astragalus sinensis contains flavonoid glycosides, amino acids, sugars and volatile oils. Its pharmacological effects are: 1 local anesthetic effect, 2 antipyretic, analgesic effect, 3 antibacterial effect, 4 effects on blood pressure. Indications: Hurricane, cold, water, open. Treatment of cold headache, nose, toothache, phlegm and cough, rheumatism and pain. Wujiapi, Wujia's root bar contains volatile oil (for 4-methyl salicylaldehyde, etc.), tannin, palmitic acid, linolenic acid and vitamin bismuth, B l D sessile root plus sesamin, sprinkle Ning, syrup resin phenolic monoglucoside (five plus bismuth B) and mannose glucoside (five plus 甙 D) and other lignan components, also contains carotenol, cardiac sputum and saponin. Further, it contains a water-soluble polysaccharide such as polyglucose and an alkali-soluble polysaccharide, and the latter is hydrolyzed to produce galacturonic acid, glucose, arabinose, rhamnose, xylose and the like. The root of Acanthopanax senticosus contains a variety of glycocalyx, including carrot sterol, 7-hydroxy-6, 8-dimethoxy coumarin ct-glucoside, ethyl alpha-galactose, syringe phenol glucoside, Lilac and so on. In addition, it also contains sesamin and polysaccharide (2.3 to 5. 7 ° /.). The stem contains sugar V. 6 ~ 1. 5%). The fruit contains 17-20% water-soluble polysaccharide, which contains pectin shield. Its pharmacological effects are: 1. Pharmacological action of sessile sessile plus 1 anti-inflammatory effect, 2 analgesic, antipyretic effect, 3 cardiovascular effects; Pharmacological action of Acanthopanax senticosus, Acanthopanax senticosus is better than ginseng "Adapt to the original, and the role of the function. Indications: Rheumatism, strong bones, blood circulation to go to the phlegm. Treatment of cold and dampness, rapid bones and muscles, low back pain, impotence, weak feet, late child, edema, athlete's foot, sore throat, swelling, pain, Bruises and bruises. Guizhi, its pharmacological effects are: 1 antibacterial effect, 2 antiviral effect, 3 diuretic use. The main functions are: sweating and relieving muscles, warming the veins. Treatment of cold and cold syndrome, shoulder and back muscles are sore, chest and drink. Achyranthes, its root contains triterpenoid saponin, hydrolyzed to form oleanolic acid, and contains a lot of potassium salt. The seeds also contain triterpenoid saponins, which are the same as those contained in the roots. It also contains ecdysterone, and cofone. Its pharmacological effects are: 1 the effect on the uterus, 2 on the intestinal tract, 3 on the cardiovascular system, 4 analgesic effect. The main function of the function is: the use of scattered blood, dissipate swelling. Gonorrhea, hematuria, amenorrhea, symptoms, dystocia, cytoplasmic, postpartum bloody abdominal pain, throat, bloated, bruises. Cooked liver and kidney, strong bones and muscles. Treating the waist and knee pain, hehe. Chuanxiong, its roots contain volatile oil, alkaloids, phenolic components, lactones, ferulic acid. Its pharmacological effects are: 1 the role of the central nervous system, 2 antihypertensive effect, 3 pairs of smooth muscle, 4 antibacterial effects. Function and Indications: Live blood, hurricane and pain. For irregular menstruation, menstrual dysmenorrhea, symptoms of abdominal pain, chest pain, tingling, swelling, pain, headache, rheumatism and pain. Xu Changqing, the whole grass contains peony phenol about 1 ° /», and finds the substance which is very similar to the meat coral 甙 yuan, the deacetylated cow 甙 、 yuan, the hairy milk vine and the acyl radix and the acetic acid, cinnamon Acid, etc. The root contains flavonoid glycosides, sugars, amino acids, and peony. Function and Indications: phlegm and dampness, relieve pain and relieve itching. For rheumatic pain, stomach pain, fullness, toothache, low back pain, falling pubar damage; urticaria, eczema. % 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 24 Hangbai glutinous root contains six kinds of furan coumarin: iso-Parsin B, isoflavin B, bergamot lactone, coralin, oxidized praerupin, hydrated oxidized praer. Its pharmacological action is: antibacterial effect. Function and Indications: Disperse wind and dehumidification, relieve pain, relieve swelling and discharge pus. For cold headache, eyebrow pain, stuffy nose, nose, toothache, vaginal discharge, sore throat.莪 ,, function and indications: qi and blood, eliminate the pain. For syndromes, blood stasis, food and pain; early cervical cancer. Red Eucommia, Source: This product is a bamboo. ^ > Branch plant Red eucommia Parabarium chunianum Ts iang, Phyllostachys pubescens Parabarium huait ingi i Chun et Tsiang, eucommia Parabarium micranthun (A. DC.) Pierre or flower vine vine Ecdysanthera Ut il is Hay. et Kaw. Dry bark, function and indications: hurricane active, strong waist and knees, strong bones, swelling. For polio, rheumatism, bruises, bruises. Big Luo Umbrella, Source: Dry roots of the legumes Mi l lettia pulchra ( Colebr. ) Kurz forma laxior Dunn. Small Luo umbrella, Source: Dry root of Ardis ia crenata Sims. Function and Indications: Blood circulation and menstruation, hurricane dehumidification. Treatment of menstruation, dysmenorrhea, rheumatism, pain, bruises. Double-sided needle, function and indications: qi and pain, blood circulation, phlegm and wind. It is used for stagnation and blood stasis caused by stagnation of blood stasis, rheumatism, stomach pain, toothache, poisonous snake bite; external treatment of soup fire burns. Function and use: This product is a stupid and phenanthridine alkaloid. The survival rate of P388 and L1210 leukemia mice is better, the life extension rate of Ehrlich ascites mice is '250%, and the life extension rate of AL771 is about 150%. HeLa cells have a significant cytotoxic effect at 1 μg/ml. It is possible to extract amphoteric alkaloids such as amphotericin 26 and chlorinated amphotericin 27. Huang Teng, Function and Indications: Detoxification. For gynecological inflammation, surgical infections, bacillary dysentery, enteritis, respiratory and urinary tract infections, conjunctivitis. The roots of the yellow vine include palmophylline, radix decoction, arbutin, scutellaria, scutellaria, yellow vine lactone, and sterol. Scorpion, function and indications: diarrhea in addition to annoyance, heat diuretic, cooling blood detoxification. For fever, upset, jaundice, red blood, bloody pain, bloody vomiting, red eyes and swelling, fire sores; external treatment, contusion and pain. 05%。 The rim, the small black triangle with volatile oil 0. 05%. Function and Indications: Breaking blood and eliminating qi, relieving pain. For the symptoms of sputum, blood stasis, food and pain. Agarwood, containing agarwood spirulina, a-agarfurfuran, B-agarfurfuran, dihydrofuran furan, demethylfuran, 4-hydroxydihydrofuran, 3,4-dihydroxydihydrofuran, eugenol; Function and Indications: Qi and pain, warm and stop vomiting, gas and asthma. For chest and abdomen swelling and pain, stomach cold vomiting hiccups, kidney deficiency gas and asthma.
本发明组方中, 以大罗伞消肿、 止痛、 化瘀,小罗伞活血、 祛风湿,徐 长卿祛风、 止痛、 通络共为主药。 配以三棱、 莪术、 两面针、 川芎、 牛膝 等活血化瘀药, 以加强主药消肿止痛功效, 又配以桂枝、 荆芥、 防风、 细 辛疏风祛寒, 木香、 沉香、 白芷、 樟脑行气止痛, 消肿化湿, 再配以五加 皮、 杜仲以强筋骨、 通经络、 祛风湿, 共为辅药。 在以上一派温热药中, 配以寒凉之品的黄藤、 栀子以凉血解毒为佐药。 相反相乘。 再配薄荷脑以 驱风并调和诸药, 以用于皮肤或粘膜产生清凉之感为佐使。 诸药合用, 有 消肿止痛、 活血化瘀、 驱风通络、 祛寒化湿功效, 用于风寒湿痹、 肩周炎、 急性扭挫伤等。 具体实施方式 In the group of the invention, the big Luo umbrella is used for swelling, relieving pain, phlegm, sputum, blood stasis, rheumatism, Xu Changqing, phlegm, pain relief, and collateral. With three edges, scorpion, two-sided needle, Chuanxiong, Achyranthes Such as activating blood circulation to remove phlegm, in order to strengthen the main medicine swelling and pain relief effect, and with cassia twig, schizonepeta, wind, spleen, wind and cold, woody, agarwood, white peony, camphor qi and pain, swelling and dampness, It is supplemented with Wujiapi, Eucommia with strong bones, Tongjingluo and Rheumatoid arthritis. In the above-mentioned warm medicine, the yellow vine and the scorpion with the cold and cool products are used as the adjuvant for cooling blood and detoxification. The opposite is multiplied. It is then blended with menthol to repel and repel various medicines for use in the skin or mucous membranes to produce a cool feeling. The combination of various medicines has the effects of reducing swelling and relieving pain, promoting blood circulation and removing blood stasis, driving wind and collaterals, and relieving cold and dampness. It is used for cold and dampness, frozen shoulder, and acute contusion. detailed description
实施例  Example
实施例 1  Example 1
防风 47 荆芥 70 细辛 50  Windproof 47 Nepeta 70 Asarum 50
牛膝 70 川芎 50 徐长卿 30  Achyranthes 70 Sichuan Chuan 50 Xu Changqing 30
莪术 60 大罗伞 110 小罗命 55  莪术 60 大罗伞 110 小罗命 55
两面针 100 三棱 85  Double-sided needle 100 three-sided 85
将以上除樟脑、 薄荷脑外的其余原料药粉碎成粗粉, 依照制备流浸膏 剂与浸膏剂的渗漉法(参见中国药典 2000年版一部附录 10 ), 用 7200重 量份 85%乙醇作溶剂, 浸渍 15小时, 以每分钟约 5ml的速度缓缓渗漉, 收 集漉液, 另器保存; 取樟脑、 薄荷脑加 550 重量份 75%乙醇使溶解后, 与 上述漉液混匀, 静置 28小时, 滤过, 即得本发明的酊剂。  The above-mentioned raw materials other than camphor and menthol are pulverized into coarse powder according to the method of preparing a liquid extracting agent and an extracting agent (see Appendix 10 of the Chinese Pharmacopoeia 2000 edition), using 7200 parts by weight of 85% ethanol as a solvent. After immersion for 15 hours, slowly percolate at a rate of about 5 ml per minute, collect the sputum, and store it again; take camphor and menthol and add 550 parts by weight of 75% ethanol to dissolve, mix with the above sputum, and let stand. After 28 hours, it was filtered to obtain the expectorant of the present invention.
实施例 2  Example 2
防风 60 荆芥 80 . 细辛 50  Windproof 60 Nepeta 80 . Asahi 50
牛膝 55 川芎 65 徐长卿 75 莪术 47 大罗伞 110 小罗伞 85 Achyranthes 55 Chuanxi 65 Xu Changqing 75 莪术47 大罗伞110 小罗伞85
两面针 110 三棱 85 樟脑 90  Double-sided needle 110 Triangular 85 Camphor 90
薄荷脑 40  Menthol 40
将以上除樟脑、 薄荷脑外的其余原料药粉碎成粗粉, 依照制备流浸膏 剂与浸膏剂的渗漉法(参见中国药典 2000年版一部附录 10 ), 用 7000重 量份 53%乙醇作溶剂, 浸渍 15小时, 以每分钟约 5ml的速度緩緩渗漉, 收 集漉液, 另器保存; 取樟脑、 薄荷脑加 500 重量份 95%乙醇使溶解后, 与 上述漉液混匀, 静置 20小时, 滤过, 即得本发明的酊剂。  The above raw materials other than camphor and menthol are pulverized into coarse powder, according to the method of preparing a liquid extracting agent and a leaching agent (see Appendix 10 of the Chinese Pharmacopoeia 2000 edition), using 7000 parts by weight of 53% ethanol as a solvent. After immersion for 15 hours, slowly percolate at a rate of about 5 ml per minute, collect the sputum, and store it again; take camphor and menthol and add 500 parts by weight of 95% ethanol to dissolve, mix with the above sputum, and let stand. After 20 hours, it was filtered to obtain the expectorant of the present invention.
实施例 3  Example 3
防风 47 荆芥 65 细辛 47  Windproof 47 Nepeta 65 Asa 47
桂枝 47 牛膝 47 川芎 30  桂枝 47 Achyranthes 47 Chuanxiong 30
徐长卿 47 白芷 70 莪术 30  徐长卿 47 白芷 70 莪术 30
红杜仲 70 大罗伞 100 小罗伞 70  Red Eucommia 70 Daluo Umbrella 100 Ronaldo Umbrella 70
两面针 120 三棱 55 樟脑 55  Double-sided needle 120 triangular 55 camphor 55
薄荷脑 90  Menthol 90
将以上除樟脑、 薄荷脑外的其余原料药粉碎成粗粉,  The above raw materials other than camphor and menthol are pulverized into coarse powder.
剂与浸膏剂的渗漉法 (参见中国药典 2000年版一部附录 10 ), 用 8000重 量份 75%乙醇作溶剂, 浸渍 30小时, 以每分钟约 3ml的速度緩緩渗漉, 收 集漉液, 另器保存; 取樟脑、 薄荷脑加 800 重量份 53%乙醇使溶解后, 与 上述漉液混匀, 静置 24小时, 滤过, 即得本发明酊剂。 The osmosis method of the agent and the extract (see Appendix 10 of the Chinese Pharmacopoeia 2000 edition), using 8000 parts by weight of 75% ethanol as a solvent, immersing for 30 hours, slowly oozing at a rate of about 3 ml per minute, collecting sputum, The device was preserved; the camphor and menthol were added with 800 parts by weight of 53% ethanol to dissolve, and then mixed with the above mash, allowed to stand for 24 hours, and filtered to obtain the elixirs of the present invention.
实施例 4  Example 4
木香 30 防风 80 荆芥 30  Woody 30 Windproof 80 Nepeta 30
细辛 30 五加皮 80 桂枝 30 牛膝 30 川芎 50 徐长卿 60 Asahi 30 five plus skin 80 cassia 30 Achyranthes 30 Chuanxi 50 Xu Changqing 60
白芷 30 莪术 50 红杜仲 55  White 芷 30 莪 50 50 Red Eucommia 55
大罗伞 120 小罗伞 80 两面针 85  Big Luo umbrella 120 small Luo umbrella 80 double needle 85
黄藤 80 栀子 110 三棱 90  Yellow vine 80 scorpion 110 Triangular 90
樟脑 40 薄荷脑 80  Camphor 40 menthol 80
按本领域常规的制剂工艺制备成乳剂。  An emulsion is prepared according to a conventional formulation process in the art.
实施例 5  Example 5
木香 47 防风 30 荆芥 47  Woody 47 windproof 30 Nepeta 47
细辛 67 五加皮 47 桂枝 80  Asarum 67 Wujiapi 47 Guizhi 80
牛膝 80 川芎 80 徐长卿 80  Achyranthes 80 Chuanxiong 80 Xu Changqing 80
白芷 80 莪术 80 红杜仲 90  白芷 80 莪术 80 Red Eucommia 90
大罗伞 85 小罗伞 90 两面针 110  Big Luo umbrella 85 Luo Luo umbrella 90 double needle 110
黄藤 90 梔子 85 三棱 70  Yellow vine 90 栀子 85 三棱 70
沉香 20 樟脑 70 薄荷脑 55  Agarwood 20 camphor 70 menthol 55
将以上除樟脑、 薄荷脑外,其余原料药粉碎成粗粉, 依照制备流浸膏 剂与浸膏剂的渗漉法(参见中国药典 2000年版一部附录 10 ), 用 7500重 量份 95%乙醇作溶剂, 浸渍 28小时, 以每分钟约 3ml的速度緩緩渗漉, 收 集漉液, 回收酒精,得清膏; 取樟脑、 薄荷脑加 650重量份 70%乙醇使溶解 后, 与上述清膏混匀, 静置 48小时, 滤过, 加水 3000重量份调节即得本 发明水剂。  Except for the above camphor and menthol, the other raw materials are pulverized into coarse powder, according to the percolation method for preparing the extract extract and the extract (see Appendix 10 of the Chinese Pharmacopoeia 2000 edition), using 7500 parts by weight of 95% ethanol as a solvent. , immersed for 28 hours, slowly permeate at a rate of about 3 ml per minute, collect sputum, recover alcohol, and obtain clear paste; take camphor, menthol and add 650 parts by weight of 70% ethanol to dissolve, mix with the above-mentioned clear paste After standing for 48 hours, filtering, adding 3000 parts by weight of water to adjust the water agent of the present invention.
实施例 6  Example 6
木香 55 防风 60 荆芥 35  Woody 55 windproof 60 Nepeta 35
细辛 4G 五加皮 47 桂枝 47 牛膝 40 川芎 50 徐长卿 40 Asahi 4G Five Plus Skin 47 Guizhi 47 Achyranthes 40 Chuanxi 50 Xu Changqing 40
白芷 35 莪术 47 红杜仲 80  White 芷 35 莪 47 47 Red Eucommia 80
大罗伞 110 小罗伞 90 两面针 90  Big Luo umbrella 110 small Luo umbrella 90 double needle 90
黄藤 85 栀子 85 三棱 70  Yellow vine 85 栀子 85 三棱 70
沉香 32. 5 樟脑 70 薄荷脑 55  Agarwood 32. 5 camphor 70 menthol 55
将以上除樟脑、 薄荷脑外,其余原料药粉碎成粗粉, 依照制备流浸膏 剂与浸膏剂的渗漉法(参见中国药典 2000年版一部附录 10 ), 用 7600重 量份 79%乙醇作溶剂, 浸渍 28小时, 以每分钟约 3ml的速度緩緩渗漉, 收 集漉液, 回收酒精,得清膏; 取樟脑、 薄荷脑加 700重量份 85%乙醇使溶解 后, 与上述清膏混匀, 静置 48小时 : 滤过, 加水 8000重量份调节即得本 发明水剂。 Except for the above camphor and menthol, the other raw materials are pulverized into coarse powder. According to the method of preparing the infiltrative paste and the extracting agent (see Appendix 10 of the Chinese Pharmacopoeia 2000 edition), 7600 parts by weight of 79% ethanol is used as a solvent. After immersion for 28 hours, slowly percolate at a rate of about 3 ml per minute, collect sputum, recover alcohol, and obtain a clear paste; take camphor, menthol and add 700 parts by weight of 85% ethanol to dissolve, and mix with the above-mentioned clear paste. , standing for 48 hours : filtration, adding 8000 parts by weight of water to adjust the water agent of the present invention.
实施例 7  Example 7
木香 60 防风 75 荆芥 80  Woody 60 Windproof 75 Nepeta 80
细辛 65 五加皮 60 桂枝 65  Asarum 65 Wujipi 60 Guizhi 65
牛膝 70 川芎 80 徐长卿 80  Achyranthes 70 Sichuan Chuan 80 Xu Changqing 80
白芷 65 莪术 70 红杜仲 90  白芷 65 莪术 70 红乌仲 90
大罗伞 110 小罗伞 80 两面针 100  Big Luo umbrella 110 small Luo umbrella 80 double needle 100
黄藤 90 栀子 85 三棱 70  Yellow vine 90 栀子 85 三棱 70
沉香 20 樟脑 60 薄荷脑 55  Agarwood 20 camphor 60 menthol 55
将以上除樟脑, 薄荷脑外,其余原料药粉碎成粗粉, 依照制备流浸膏 剂与浸膏剂的渗漉法(参见中国药典 2000年版一部附录 10 ), 用 7500重 量份 90%乙醇作溶剂, 浸渍 28小时, 以每分钟约 3ml的速度緩緩渗漉, 收 集漉液, 回收酒精,得清膏; 取樟脑、 薄荷脑加 650重量份 70%乙醇使溶解 后, 与上述清膏混匀, 静置 48小时: 滤过, 加水 4500重量份调节即得本 发明水剂。 Except for the above camphor and menthol, the other raw materials are pulverized into coarse powder. According to the method of preparing the infiltrative solution and the extracting agent (see Appendix 10 of the Chinese Pharmacopoeia 2000 edition), 7500 parts by weight of 90% ethanol is used as a solvent. , immersed for 28 hours, slowly permeate at a rate of about 3 ml per minute, collect sputum, recover alcohol, and obtain clear paste; take camphor, menthol and add 650 parts by weight of 70% ethanol to dissolve Thereafter, it was mixed with the above-mentioned clear paste and allowed to stand for 48 hours: filtered, and adjusted to 4500 parts by weight of water to obtain the aqueous preparation of the present invention.
实施例 8  Example 8
木香 80 防风 60 荆芥 70  Woody 80 windproof 60 Nepeta 70
细辛 70 五加皮 30 桂枝 50  Asahi 70 Wujiapi 30 Guizhi 50
牛膝 70 川芎 50 徐长卿 40  Achyranthes 70 Sichuan Chuan 50 Xu Changqing 40
白芷 70 莪术 60 红杜仲 70  White 芷 70 莪 60 60 Red Eucommia 70
大罗伞 110 小罗伞 60 两面针 100  Big Luo umbrella 110 small Luo umbrella 60 double needle 100
黄藤 105 栀子 120 三棱 85  Yellow vine 105 栀子 120 三棱 85
沉香 40 樟脑 80 薄荷脑 50  Agarwood 40 camphor 80 menthol 50
将以上除樟脑. 薄荷脑外的其余十九味原料药粉碎成粗粉, 依照制备 流浸膏剂与浸膏剂的渗漉法(参见中国药典 2000年版一部附录 10 ),用 7500 重量份 80%乙醇作溶剂, 浸渍 15小时, 以每分钟约 5ml的速度緩緩渗漉, 收集漉液, 另器保存; 取樟脑、 薄荷脑加 600 重量份 85%乙醇使溶解后, 与上述漉液混匀, 静置 72小时, 滤过, 即得本发明的酊剂,  The above nineteen flavored raw materials other than menthol are pulverized into coarse powder, according to the method of preparing the infiltrative paste and the extracting agent (see Appendix 10 of the Chinese Pharmacopoeia 2000 edition), using 7500 parts by weight 80% Ethanol as a solvent, immersed for 15 hours, slowly permeate at a rate of about 5 ml per minute, collect sputum, and store it again; take camphor, menthol and 600 parts by weight of 85% ethanol to dissolve, mix with the above mash After standing for 72 hours and filtering, the tincture of the present invention is obtained.
实施例 9  Example 9
木香 47 防风 47 荆芥 47  Woody 47 windproof 47 Nepeta 47
细辛 47 五加皮 47 桂枝 47  Asahi 47 Wujiapi 47 Guizhi 47
牛膝 47 川芎 47 徐长卿 47  Achyranthes 47 Chuanxi 47 Xu Changqing 47
白芷 70 莪术 47 红杜仲 70  白芷70 莪术 47 红杜仲 70
大罗伞 100 小罗伞 70 两面针 100  Big Luo umbrella 100 small Luo umbrella 70 double needle 100
黄藤 80 栀子 100 三棱 70  Yellow rattan 80 scorpion 100 three-sided 70
沉香 32. 5 樟脑 55 薄荷脑 55 将以上除樟脑、 薄荷脑外的其余十九味原料药粉碎成粗粉, 依照制备 流浸膏剂与浸膏剂的渗漉法(参见中国药典 2000年版一部附录 10 ),用 7200 重量份 70%乙醇作溶剂, 浸渍 15小时, 以每分钟约 5ml的速度緩緩渗漉, 收集漉液, 另器保存; 取樟脑、 薄荷脑加 700 重量份 65%乙醇使溶解后, 与上述漉液混匀, 静置 36小时, 滤过, 即得本发明的酊剂。 Agarwood 32. 5 camphor 55 menthol 55 The above nineteen flavors of the raw materials other than camphor and menthol are pulverized into coarse powder, according to the method of preparing the infiltrative paste and the extracting agent (see Appendix 10 of the Chinese Pharmacopoeia 2000 edition), using 7200 parts by weight 70% Ethanol as solvent, immersed for 15 hours, slowly permeate at a rate of about 5 ml per minute, collect sputum, and store it again; take camphor, menthol and add 700 parts by weight of 65% ethanol to dissolve, mix with the above mash After standing for 36 hours and filtering, the tincture of the present invention was obtained.
实施例 10  Example 10
木香 70 防风 60 荆芥 70  Woody 70 windproof 60 Nepeta 70
细辛 70 五加皮 60 桂枝 50  Asarum 70 Wujiapi 60 Guizhi 50
牛膝 70 川芎 50 徐长卿 40  Achyranthes 70 Sichuan Chuan 50 Xu Changqing 40
白芷 70 莪术 60 红杜仲 70  White 芷 70 莪 60 60 Red Eucommia 70
大罗伞 110 小罗伞 60 两面针 100  Big Luo umbrella 110 small Luo umbrella 60 double needle 100
黄藤 85 栀子 90 三棱 85  Yellow vine 85 栀子 90 三棱 85
沉香 25 樟脑 80 薄荷脑 50  Agarwood 25 camphor 80 menthol 50
将以上除樟脑、 薄荷脑外的其余十九味原料药粉碎成粗粉, 依照制备 流浸膏剂与浸膏剂的渗漉法(参见中国药典 2000年版一部附录 10 ),用 7800 重量份 60%乙醇作溶剂, 浸渍 15小时, 以每分钟约 5ml的速度緩緩渗漉, 收集漉液, 另器保存; 取樟脑、 薄荷脑加 700 重量份 60%乙醇使溶解后, 与上述漉液混匀, 静置 60小时, 滤过, 即得本发明的酊剂。  The above nineteen flavored raw materials other than camphor and menthol are pulverized into coarse powder according to the method of preparing a liquid extracting agent and an extracting agent (see Appendix 10 of the Chinese Pharmacopoeia 2000 edition), using 7800 parts by weight and 60%. Ethanol as a solvent, immersed for 15 hours, slowly permeate at a rate of about 5 ml per minute, collect sputum, and store it again; take camphor, menthol and add 700 parts by weight of 60% ethanol to dissolve, mix with the above mash After standing for 60 hours and filtering, the tincture of the present invention was obtained.
实施例 11  Example 11
木香 35 防风 60 荆芥 35  Woody 35 windproof 60 Nepeta 35
细辛 40 五加皮 80 桂枝 40  Asahi 40 Wujipi 80 Guizhi 40
牛膝 40 川芎 50 徐长卿 40  Achyranthes 40 Chuanxiong 50 Xu Changqing 40
白芷 35 莪术 50 红杜仲 80 大罗伞 110 小罗伞 80 两面针 90 White 芷35 莪术50 Red Eucommia 80 Big Luo umbrella 110 small Luo umbrella 80 double needle 90
黄藤 95 栀子 110 三棱 80  Yellow rattan 95 scorpion 110 triangular 80
沉香 40 樟脑 40 薄荷脑 80  Agarwood 40 camphor 40 menthol 80
将以上除樟脑、 薄荷脑外的其余十九味原料药粉碎成粗粉, 依照制备 流浸膏剂与浸膏剂的渗漉法(参见中国药典 2000年版一部附录 10 ),用 7500 重量份 80%乙醇作溶剂, 浸渍 15小时, 以每分钟约 5ml的速度緩緩渗漉, 收集漉液, 另器保存; 取樟脑、 薄荷脑加 600 重量份 60%乙醇使溶解后, 与上述漉液混匀, 静置 24小时, 滤过, 即得本发明的酊剂。  The above nineteen flavored raw materials other than camphor and menthol are pulverized into coarse powder according to the method of preparing the infiltrative solution of the flow extract and the extract (see Appendix 10 of the Chinese Pharmacopoeia 2000 edition), using 7500 parts by weight 80%. Ethanol as a solvent, immersed for 15 hours, slowly permeate at a rate of about 5 ml per minute, collect sputum, and store it again; take camphor, menthol and 600 parts by weight of 60% ethanol to dissolve, mix with the above mash After standing for 24 hours and filtering, the tanning agent of the present invention was obtained.
本发明中药制剂一一 "消肿止痛酊" 的动物药效学试验资料: 摘要: 消肿止痛酊剂系广西柳州市中药总厂研制的中药制剂酊剂。 药 效学试验表明: 局部涂药可明显扩张小鼠耳廊毛细血管, 明显促进兔耳血 斑的吸收; 局部涂药及 ig 给药均可抑制巴豆油所致的小鼠耳廊肿胀及小 鼠皮下棉球肉芽肿的增生; 但 ig 给药对醋酸所致的腹膜炎症渗出无明显 影响; 局部涂药及 ig给药均对小鼠热板致痛有一定的镇痛作用, ig给药 对小鼠醋酸刺激致痛有明显的镇痛作用; 局部涂药有促进小鼠软组织挫伤 修复的作用, 体外对大肠杆菌的最小抑菌浓度为 1: 10, 对金黄色葡萄球 菌及乙型链球菌为 1: 20。  The pharmacodynamic test data of the traditional Chinese medicine preparation of the invention is as follows: The anti-tumor and analgesic tincture is a traditional Chinese medicine preparation tincture developed by Guangxi Liuzhou Traditional Chinese Medicine General Factory. Pharmacodynamic tests showed that: local application can significantly expand the capillaries of mouse ear canal, and obviously promote the absorption of blood spots in rabbit ears; local application and ig administration can inhibit the swelling and smallness of mouse ear canal caused by croton oil. The proliferation of cotton granuloma in the subcutaneous skin of rats; but the administration of ig has no obvious effect on the percolation of peritoneal inflammation caused by acetic acid; local application and ig administration have certain analgesic effect on the pain caused by hot plate in mice, ig The drug has obvious analgesic effect on the stimulation of acetic acid in mice. The topical application has the effect of promoting the repair of soft tissue contusion in mice. The minimum inhibitory concentration against Escherichia coli in vitro is 1:10, against Staphylococcus aureus and B. Streptococcus is 1:20.
[本品及供试品]  [This product and test article]
消肿止痛酊系广西柳州市中药总厂研制的中药酊剂, 含醇 55%, 临床 用于跌打扭伤、 风湿骨痛、 无名肿毒、 腮腺肿痛等症。 外用适量涂患处; 必要时可饭前口服, 每次 5— 10ml , 每曰 2次。  It is a traditional Chinese medicine tincture developed by Guangxi Liuzhou Traditional Chinese Medicine Factory. It contains 55% alcohol. It is used for bruises, rheumatoid bone pain, nameless swollen, parotid swelling and pain. Apply a proper amount to the affected area; if necessary, take it orally before meals, 5-10 ml each time, 2 times per sputum.
供试品: 为本品(批号 940402 )及其 2 倍浓药液(含醇 55% ), 由柳 州市中药总厂提供。 本文所述剂量均以 "本品 ml" 表示。 Test sample: This product (batch number 940402) and its 2 times concentrated liquid (55% alcohol), provided by Liuzhou Chinese Medicine General Factory. The doses described herein are expressed in "this product ml".
[实验材料]  [Experimental Materials]
昆明种小白鼠, 普通级, ? δ兼用, 由要所动物室提供, 喂颗料饲料。 日本大耳白兔, ? ί兼用, 体重 2. 5— 3. 0kg, 由本所动物室提供。 喂 固体饲料及青菜。  Kunming mice, ordinary grade, ? δ is used in combination, supplied by the animal room, feeding the pellet feed. Japanese big white rabbit, ? ί用用, Weight 2. 5 — 3. 0kg, provided by our animal room. Feed solid feed and greens.
菌种: 大肠杆菌 ( 44102 ), 金黄色葡萄球菌 ( 26003 )、 乙型链球菌 ( 32172 ), 由中国药品生物制品检定所提供。  Species: Escherichia coli (44102), Staphylococcus aureus (26003), Streptococcus mutans (32172), provided by China National Institute for the Control of Pharmaceutical and Biological Products.
细菌培养基: 普通肉汤培养基、 伊红美蓝琼脂培养基、 甘露醇高盐琼 脂培养基、 血 脂培养基、 血清肉汤培养基, 按卫生部 《药品卫生检验方 法》 由本所抗生素室制备。  Bacterial culture medium: common broth medium, eosin blue agar medium, mannitol high salt agar medium, blood lipid medium, serum broth medium, prepared by our antibiotic room according to the Ministry of Health "Drug Hygiene Test Method" .
冯了性风湿跌打药酒: 广东佛山市制药一厂出品, 批号 9309086, 含 醇 35—45%。 用时可在 6(TC水浴加热浓缩至原体积的一半, 挥去部份乙醇, 再加水到所需体积。  Feng rheumatoid beaten medicinal liquor: produced by Foshan Pharmaceutical First Factory, Guangdong, batch number 9309086, containing alcohol 35-45%. When used, it can be concentrated in 6 (TC water bath to half of the original volume, and part of the ethanol is removed, and water is added to the required volume.
无水乙醇: 安徽特级酒精总厂出品, 批号 931220。 用去离子水稀释适 宜浓度供试。 Absolute ethanol: produced by Anhui Super-Grade General Factory, batch number 9312 2 0. Dilute the appropriate concentration with deionized water for testing.
巴豆油混合致炎剂: 本室配制。 0. 5%伊文思蓝: 本室配制。 0. 7%醋酸 本室配制。  Croton oil mixed inflammatory agent: This room is prepared. 0. 5% Evans Blue: This room is prepared. 0. 7% acetic acid This room is prepared.
灭菌干棉球(20mg/只): 本室制备。  Sterilized dry cotton balls (20mg / only): Prepared in this room.
CHEM— 5半自动生化分析仪: 日本 ERBA公司产。  CHEM-5 semi-automatic biochemical analyzer: produced by Japan ERBA.
[实验条件]  [Experimental conditions]
实验室温 25 土 1 °C (空调), 相对湿度 65 ± 5%, 其它条件见 "实验材 料" 项。  Experimental room temperature 25 ° 1 °C (air conditioning), relative humidity 65 ± 5%, see "Experimental materials" for other conditions.
[实验方法及结果] 1、 本品外涂对小鼠耳廊微血管的影响试验 [Experimental methods and results] 1. Effect of external application of this product on microvessels in mouse ear canal
取小鼠 50只, 体重 18— 21g, ? S兼用, 随机均分为 5组。 各鼠 ip 戍巴比妥钠麻醉, 将左耳廓涂石腊油贴于载玻片上, 麻醉 l Omin后, 于装 有量尺的显微镜下( 10 X 4倍)观察耳廓耳尖 A第 3个分枝处的毛细血管 直径(刻度单位),作为药前值,随即给药: 高、低剂量组分别按本品 0. 2ml/ 耳(用本品 2倍浓药液 0. 1/耳)、 0. 1ml/耳轻滴于耳廓; 乙醇组以 55%乙醇 滴耳廓。 各组给药体积均为 0. 1ml/耳。 药后每 5min观察同一部位的血管 直径, 连续 15min, 以血管直径变化最大值作为药皇值, 按下式计算血管 扩张率及血管扩张度, 与空白组比较, 作组间 t检验。 结果见表 1。  Take 50 mice, weighing 18-21g, ? S is used in combination, and is randomly divided into 5 groups. Each mouse was anesthetized with barbiturate sodium, and the left auricle was coated with paraffin oil on a glass slide. After anesthesia for 10 minutes, the auricle tip A was observed under a microscope equipped with a ruler (10 X 4 times). The diameter of the capillary at the branch (scale unit), as a pre-medication value, immediately administered: high and low dose group according to the product 0. 2ml / ear (use this product 2 times concentrated liquid 0. 1 / ear ), 0. 1ml / ear lightly on the auricle; ethanol group with 55% ethanol drop auricle. The dosage volume of each group was 0.1 ml/ear. The blood vessel diameter of the same site was observed every 5 minutes after the drug for 15 minutes. The maximum value of the blood vessel diameter was used as the drug value. The vasodilation rate and vasodilatation degree were calculated according to the following formula, and compared with the blank group, the t-test was performed between groups. The results are shown in Table 1.
血管扩张率 = 二 雌 xVasodilatation rate = two female x simple
药 值  Drug value
血管扩张度 = 药后值 -药前值 Vasodilatation = post-drug value - pre-medication value
表 1、 对小鼠耳廓微血管的影响结果 ( ±SD) Table 1. Results of mouse auricle microvessels (±SD)
剂量 药前值 扩张度  Dose pre-drug value
组别 n 扩张率  Group n expansion rate
(ml/耳) (刻度单位) (刻度单位) 高剂量组 10 0.2 3.5 ±0.53 0.60 ±0.39*** 17.9 ±11.8***  (ml/ear) (scale unit) (scale unit) high dose group 10 0.2 3.5 ±0.53 0.60 ±0.39*** 17.9 ±11.8***
低剂量组 10 0.1 3.50 ±0.53 0.70 ±0.59** 21.7 ±19· 6** Low dose group 10 0.1 3.50 ±0.53 0.70 ±0.59** 21.7 ±19· 6**
冯了性组 10 0.1 3.75 ±0.79 0.65士 0.41*** 19.8 ±13.7** Feng's sexual group 10 0.1 3.75 ±0.79 0.65 ± 0.41*** 19.8 ±13.7**
空白组 10 0.1 3.35 ±0.47 0.10 ±0.21 3.1 ±6.5 Blank group 10 0.1 3.35 ±0.47 0.10 ±0.21 3.1 ±6.5
乙醇组 10 0.1 3.42 ±0.51 0.25 ±0.23* 9.3 ±11.4* Ethanol group 10 0.1 3.42 ±0.51 0.25 ±0.23* 9.3 ±11.4*
注: 与空白组比较, *P.〉0.05, **p< 0.05, ***p< o.01, 下同 与乙醇組比较, P>0.05, P<0.05 P<0.01, 下同 Note: Compared with the blank group, *P.>0.05, **p< 0.05, ***p< o.01, the same as the ethanol group, P>0.05, P<0.05 P<0.01, the same below
结果可见, 本品高、 低剂量组的血管扩张度及 张率均大于空白組及 乙醇组,差异有显著或非常显著性意义, 提示本品耳廓皮肤滴药, 对小鼠 耳廓毛细血管有一定的扩张作用。  The results showed that the vasodilation and the tensor rate of the high- and low-dose groups were higher than those in the blank group and the ethanol group. The difference was significant or very significant, suggesting that the product of the auricle skin drops the mouse auricle capillaries. There is a certain expansion effect.
2、 本品外涂对兔耳皮下血斑吸收的影响试验  2. Effect of external application of this product on the absorption of blood spots under rabbit skin
取兔 30 只, $各半, 随机均分为 5 组, 每兔均作耳廓皮下血斑造 型: 于耳背皮下注入自身抗凝血液 0.2ml成血丘, 用内径 1.6cm的玻管套 压在血丘周围, 以直径相宜前端平截的蕊捧从玻管内轻压血丘, 形成面积 约 2CM2血斑。 每耳造血斑两个, 相距约 3CM。 造型后 4h, 测量各血斑面积 作为药前值, 承即给药: 高、 低剂量组分别按 0.2ml/班(本品的 2倍浓药 液 0.1ml/班), 0.1ml/班给本品; 阳性对照组及空白对照组均按 0. lml/斑 分別给冯了性药酒及去离子水; 酒精组给 55%乙醇 0.1 他 ml/斑, 均为血 斑(表面皮肤涂药, 每天 1 次。 给药后每隔 24 小时测量血斑面积 1次, 并计算血斑吸收率 X 100%, 药后 ^二¾前值与空白组比较, 作组间 t检验。 Take 30 rabbits, each half, randomly divided into 5 groups, each rabbit is used for subcutaneous blood spotting of the auricle: Inject 0.2 ml of anti-coagulant liquid into the blood mound under the skin of the ear, and press with a glass tube with an inner diameter of 1.6 cm. Around the blood dome, the blood core is gently pressed from the glass tube with a diameter of the front end of the curved section, forming an area of about 2CM 2 blood spots. Two blood spots per ear, about 3CM apart. 4h after modeling, the area of each blood spot was measured as the pre-medication value, and the administration was as follows: The high- and low-dose groups were respectively 0.2 ml/shift (0.1 ml/class of 2 times concentrated solution of this product), 0.1 ml/class This product; the positive control group and the blank control group were given 0. lml/ spot respectively to Feng medicinal liquor and deionized water; alcohol group to 55% ethanol 0.1 heml / spot, all blood spots (surface skin coating, Once a day. The blood spot area was measured once every 24 hours after administration, and the blood spot absorption rate X 100% was calculated. The value before the drug was compared with the blank group to make an inter-group t test.
药刖值  Drug value
结果见表 2。 The results are shown in Table 2.
表 2、 对兔耳皮下血斑吸收影响结果 ( 土 SD ) 剂量 药前值 药后血斑吸收率 Table 2. Effect of subcutaneous blood spot absorption on rabbit ears (Soil SD) Dose Pre-medication value Blood spot absorption rate after drug
组 另' J n  Group another ' J n
(ml/斑) (cm2) (ml/spot) (cm 2 )
24h 48h 72h 96h 高剂量组 6 0.2 2.18±0.36 2.4 ±44.5* 67.1 ± 13.3*** 93.0±9.8*** 100.0± 0*** 低剂量組 6 0.1 2.29 ±0.26 3.8 + 23.6* 48.7 + 9.6*** 69.9 ±13.5* 91.8 ±21.3* 冯了性组 6 0.1 2.30 ±0.29 20.4 ±24.2*** 41.6 ±17.7** 71.0±20.8* 90.7 ±14.6* 空白组 6 0.1 2.14 ±0.25 - 9.1±25.1 26.0±18.4 62.0±24.2 73.1±20.6 乙醇组 6 0.1 2.08 ±0.17 4.1±18.6* 37.1±22.3* 69.1 ±21.4* 81.3 ±17.1* 24h 48h 72h 96h high dose group 6 0.2 2.18±0.36 2.4 ±44.5* 67.1 ± 13.3*** 93.0±9.8*** 100.0± 0*** Low dose group 6 0.1 2.29 ±0.26 3.8 + 23.6* 48.7 + 9.6* ** 69.9 ±13.5* 91.8 ±21.3* Vortex group 6 0.1 2.30 ±0.29 20.4 ±24.2*** 41.6 ±17.7** 71.0±20.8* 90.7 ±14.6* Blank group 6 0.1 2.14 ±0.25 - 9.1±25.1 26.0 ±18.4 62.0±24.2 73.1±20.6 Ethanol group 6 0.1 2.08 ±0.17 4.1±18.6* 37.1±22.3* 69.1 ±21.4* 81.3 ±17.1*
结果可见, 本品高剂量药后血斑吸收率均高于空白组, 其中药制剂后The results showed that the blood spot absorption rate of this product was higher than that of the blank group after high dose,
48h、 72h、 96h 的血斑吸收率差异有非常显著性意义; 低剂量组药后 48h 的血斑吸收率亦高于空白组, 差异有显著性意义; 提示本品局部皮肤涂药 对兔耳皮下血斑的吸收有一定的促进作用。 The difference of blood spot absorption rate at 48h, 72h and 96h was very significant. The blood spot absorption rate of the low dose group was 48 h after the drug was higher than that of the blank group. The difference was significant. The absorption of subcutaneous blood spots has a certain promoting effect.
3、 本品局部涂药对巴豆所致小鼠耳廓肿胀的影响试验  3. Effect of topical application of this product on swelling of mouse ear caused by croton
取小鼠 84只, 体重 22—24g, ? δ兼用, 随机均分为 7组。 本品 4个 剂量组, 冯了性对照组、 乙醇对照组、 空白对照组分别给以本品、 冯了性 药酒、 55%乙醇、 去离子水, 均为每鼠左耳廓两面緩慢滴药, 0. 1ml/耳次。 给药后 lh、 7个组小鼠^以巴豆油混合致炎剂 0. 1/耳滴于左耳廓两面以致 炎。 本品 1组、 冯了性组、 乙醇组、 空白组分别于致炎后笫 1、 2、 3小时 再各同法给药; 本品第 2组、 3组 4组于致炎后第 1小时同法再给药 1次 (取本品 5ml加 55%乙醇成 10ml供第 3组用 , 取本品 2. 5ml加 55%乙醇成 10ml供第 4组用)。 致炎后 4h, 拉颈处死小鼠, 剪下左、 右耳廓, 以直径 为 8mm的打孔器分别在相对应的部位打下左、 右耳园片, 分别称重。 以左、 右耳片重量差值作为肿胀度, 以 作为肿胀率, 与空白组比较, 作 石斗片  Take 84 mice, weighing 22-24g, ? δ is used in combination and is randomly divided into 7 groups. The four dose groups of this product, the Feng control group, the ethanol control group and the blank control group were given this product, Fengjiu medicinal liquor, 55% ethanol and deionized water, all of which were slowly dripped on both sides of the left auricle of each mouse. , 0. 1ml / ear. After the administration of lh, 7 groups of mice ^ croton oil mixed inflammatory agent 0.1 1 / ear drops on both sides of the left auricle to cause inflammation. The product group 1, the phosic group, the ethanol group, and the blank group were administered in the same way after 1, 2, and 3 hours after the inflammation; the second group and the third group of the product were the first group after the inflammation. The same method is administered once more (5 ml of this product plus 55% ethanol is added to 10 ml for the third group, and the product is 2. 5 ml plus 55% ethanol to 10 ml for the fourth group). 4 hours after the inflammation, the mice were sacrificed by pulling the neck, and the left and right auricles were cut out. The left and right ear slices were respectively punched in the corresponding parts with a diameter of 8 mm, and weighed separately. The difference between the left and right ear weights is used as the swelling degree, and the swelling rate is compared with the blank group.
組间 t检验。 结果见表 3。 表 3 本品涂药对小鼠巴豆油耳炎的影响结果( 土 SD ) Inter-group t test. The results are shown in Table 3. Table 3 Effect of application of this product on croton ophthalmitis in mice ( soil SD )
组 别 n 剂量 (ml /kg) 肿胀度 (mg) 肿胀率 (%) 本品 1組 12 20 6. 5 ± 5. 1 *** 36. 1 ± 29. 5*** 本品 2组 12 10 11. 1 ± 4. 2* 66. 4 ± 25. 9* 本品 3组 12 5 13. 2 + 5. 4* 80. 1 ± 34. 1* 本品 4组 12 2. 5 11. 5 ± 3. 8* 73. 3 ± 23* 冯了性组 12 20 6. 3 ± 4. 4*** 41. 8 ± 29. 8*** 乙醇组 12 20 12. 8 ± 3. 9* 82. 2 ± 24. 9* 空白组 12 20 14. 2 ± 3. 8 90. 2 ± 29. 4* 结果可见, 本品各组的肿胀度及肿胀率均小于空白组, 其中本品第 1 组的肿胀度及肿胀率的差异有非常显著性意义, 本品第 2组肿胀率差异有 显著性意义, 第 3、 4组差异无显著性意义。 Group n dose (ml / kg) Swelling degree (mg) Swelling rate (%) This product group 1 12 20 6. 5 ± 5. 1 *** 36. 1 ± 29. 5*** This product 2 group 12 10 11. 1 ± 4. 2* 66. 4 ± 25. 9* 3 groups of this product 12 5 13. 2 + 5. 4* 80. 1 ± 34. 1* 4 groups of this product 12 2. 5 11. 5 ± 3. 8* 73. 3 ± 23* Feng group 12 20 6. 3 ± 4. 4*** 41. 8 ± 29. 8*** Ethanol group 12 20 12. 8 ± 3. 9* 82. 2 ± 24. 9* blank group 12 20 14. 2 ± 3. 8 90. 2 ± 29. 4* As a result, the swelling degree and swelling rate of each group were smaller than those of the blank group. The difference in swelling degree and swelling rate of the first group of this product was very significant. Sexual significance, the difference in swelling rate of the second group of this product was significant, and the difference between the third and fourth groups was not significant.
本品外涂对巴豆油所至耳廊肿胀的抑致作用显示出一定的量效关系趋 势。 提示本品耳廊给药对巴豆油所致的小鼠耳廊肿脉有一定的抑制作用。  The inhibitory effect of the outer coating on the swelling of the croton oil to the ear lobes showed a certain dose-effect relationship. It is suggested that the administration of the ear canal has a certain inhibitory effect on the swelling of the mouse ear canal caused by croton oil.
4、 本品 ig ^药对巴豆油所致小鼠耳廊肿胀的影响试验  4, the effect of this product ig ^ medicine on the swelling of mouse ear lobes caused by croton oil
取小鼠 72只, 体重 17— 22g, ? δ兼用, 随机均分为 6組, 高、 中、 低剂量组分别按 10ml/kg (用本品的两倍浓药液 5ml )、 5ml/kg、 2. 5ml /kg 给本品; 阳性对照组、 乙醇对照组、 空白对照给分别给冯了性红酒 10ml /kg (挥去部分乙醇, 见材料项)、 27%乙醇 10ml/kg、 去离子水 10ml/kg、 各组 给药体积均为 10ml/kg、 连续 ig给药 2天。 末海外侨胞给药后 1小时, 各 鼠左耳两面涂以巴豆没混合致炎剂 0. lml 以致炎, 致炎后 4小时, 拉颈处 死小鼠, 剪下左、 右耳廊, 用直径 8醒的打孔器在相对应的部位分别打下 左、 右耳园片、 准确称重, 以左耳片重-右耳片重的差值作肿胀度; 以 ji¾作为肿胀率, 与空白组比较, 作组间 t检验。 结果见表 4。  Take 72 mice, weighing 17-22g, ? δ is used in combination, and is divided into 6 groups at random. The high, medium and low dose groups are given 10ml/kg (5ml with twice the concentration of this product), 5ml/kg, 2. 5ml /kg respectively. The group, the ethanol control group and the blank control were given 10 ml / kg of von red wine (spent part of ethanol, see material item), 27% ethanol 10 ml / kg, deionized water 10 ml / kg, and the volume of each group was 10 ml/kg, continuous ig administration for 2 days. One hour after the administration of the overseas Chinese, the left ear of each mouse was coated with croton without mixing inflammatory agent 0. lml to cause inflammation, 4 hours after inflammation, the mice were sacrificed by pulling the neck, and the left and right ear lobes were cut. 8 wake up the puncher in the corresponding parts, respectively, the left and right ear discs, accurately weighed, the difference between the weight of the left ear and the weight of the right ear; the swelling rate, with ji3⁄4 as the swelling rate, and the blank group For comparison, a t-test between groups was performed. The results are shown in Table 4.
右耳片重 Right ear weight
表 4、 给药对小鼠巴豆油耳炎的影响结果 ( 土 SD )  Table 4. Effect of administration on croton oil ototoxicity in mice (Soil SD)
組别 n 剂量 (ml /kg) 肿胀度 (mg) 肿胀率 (%) 高剂量组 12 10 13. 5 ± 5. 5** 85. 8 ± 36. 2** 中剂量組 12 5 14. 8 ± 5. 0** 95. 9 ± 29. 2* 低剂量组 12 2. 5 16. 2 ± 5. 0* 107. 3 ± 33. 2* 冯了性组 12 10 13. 0 ± 5. 0** 86. 7 ± 32. 7** 乙醇组 12 10 16. 8 ± 6. 7* 169. 9 + 47. 3* 空白组 12 10 17. 9 ± 4. 8 120. 9 ± 32. 8 结果可见, 本品高剂量组及冯了性组的肿长度及肿胀率均小于空白组, 差异有显著性意义, 提示本品 ig 给药在较高剂量时有抑制巴豆油所致小 鼠耳廊肿胀的作用。 Group n dose (ml / kg) Swelling degree (mg) Swelling rate (%) High dose group 12 10 13. 5 ± 5. 5** 85. 8 ± 36. 2** Medium dose group 12 5 14. 8 ± 5. 0** 95. 9 ± 29. 2* Low dose group 12 2. 5 16. 2 ± 5. 0* 107. 3 ± 33. 2* Vonogenic group 12 10 13. 0 ± 5. 0** 86. 7 ± 32. 7** Ethanol group 12 10 16. 8 ± 6. 7* 169. 9 + 47. 3* blank group 12 10 17. 9 ± 4. 8 120. 9 ± 32. 8 The results show that the high dose group and the von group The length and swelling rate were lower than the blank group, and the difference was significant. It suggested that the ig administration of this product inhibited the swelling of mouse ear lobes caused by croton oil at higher doses.
5、 本品 ig给对醋酸所致腹膜症渗出的影响试验 取小鼠 78 只, 体重 18— 22g, 兼用, 随机均分为 6组, 高、 中、 低剂量组分別按 10ml /kg (用本品的 2位倍浓药液 5ml )、 5ml /kg, 2. 5 ml/kg 给本品, 阳性对照组及乙醇对照组分别给冯了性药酒 10ml/kg (挥去部份 乙醇, 见材料项)及 27%乙醇; 空白对照组给水。 给药体积均为 10ml/kg, 连续 ig给药 4天。 末次给药后 30min, 各鼠均尾静脉注射 0. 5%伊文思蓝 5ml/kg, 随即 ipO. 7%醋酸 10ml/kg, 于 ig醋权后 30min, 拉颈处死小鼠, 用适量生理盐水冲洗腹腔, 收集全部冲洗液并加重量盐水至 10ml/kg, 离 心后取上清液于 578mm处测其 DD值, 以 DD值表示冲洗液中伊文思蓝的含 量, 间接, 反映腹膜炎症渗出的程度。 与乙醇級比较, 作组间 t检验。 结 果见表 5。 表 5、 对醋酸所致小鼠腹膜炎症渗出的影响结果  5, this product ig to the effect of acetic acid-induced peritoneal exudation test 78 mice, weighing 18-22g, both, randomly divided into 6 groups, high, medium and low dose groups respectively according to 10ml / kg ( Use this product's 2 concentrating solution 5ml), 5ml /kg, 2. 5 ml/kg to give this product, the positive control group and the ethanol control group respectively give Fengjiu medicinal liquor 10ml/kg (spent part of ethanol, See material item) and 27% ethanol; blank control group for water supply. The administration volume was 10 ml/kg, and continuous ig administration was carried out for 4 days. 30 min after the last administration, each mouse was injected with 0.5% Evans blue 5 ml/kg, followed by ipO. 7% acetic acid 10 ml/kg, 30 min after ig vinegar weight, the mice were sacrificed by pulling the neck, and the amount of normal saline was used. Rinse the abdominal cavity, collect all the washing liquid and add the weight of saline to 10ml/kg. After centrifugation, take the supernatant and measure the DD value at 578mm. The DD value indicates the content of Evans blue in the washing liquid, indirectly, reflecting the peritoneal inflammation exudation. Degree. Compared with the ethanol level, an inter-group t-test was performed. The results are shown in Table 5. Table 5. Results of infiltration of peritoneal inflammation in mice induced by acetic acid
冲液液 OD ( χ 士  Liquid OD ( χ士
组别 n 剂量 (ml /kg) 抑制率(%)  Group n dose (ml / kg) inhibition rate (%)
SD ) 高剂量组 13 10 0. 240 ± 0. 071* 6. 7 中剂量组 13 5 0. 213 ± 0. 046* 5. 3 低剂量组 13 2.5 0.230 ± 0.040* 2.2 冯了性组. 13 10 0.179土 0.034*** 20.4 SD) High dose group 13 10 0. 240 ± 0. 071* 6. 7 Medium dose group 13 5 0. 213 ± 0. 046* 5. 3 Low dose group 13 2.5 0.230 ± 0.040* 2.2 von group. 13 10 0.179 soil 0.034 *** 20.4
. 乙醇组 13 10 10.025 ± 0.066*  Ethanol group 13 10 10.025 ± 0.066*
空白组 10 10 0.244 ±0.044 结果可见, 本品高、 中、 低剂量组的 D值均与乙醇组及空白组相近, 差异均无显著性意义, 冯了性组差异有非常显著性意义(P<Q. Gl。 提示 本品 ig给药对醋酸所致小鼠腹膜炎症渗出无抑制作用。  The blank group 10 10 0.244 ±0.044 The results showed that the D values of the high, medium and low dose groups of the product were similar to those of the ethanol group and the blank group, and the difference was not significant. The difference between the von group and the low group was very significant (P <Q. Gl. It is suggested that this product ig administration has no inhibitory effect on peritoneal inflammation exudation induced by acetic acid in mice.
6、 本品外涂对小鼠棉球肉芽肿增生的影响;  6. The effect of external application of this product on the proliferation of mouse cotton granuloma;
取小鼠 72只, 体重 24—26g, ? δ兼用, 随机分为 5组。 各鼠 ig戊巴 比妥钠麻醉, 剪毛, 无菌操作下将灭菌干棉球埋入背部右侧皮下, 距手术 切口约 2.5cm, 术后次日, 埋棉球表面皮肤去毛 2 X 2cm2, 将药液涂于去毛 区皮肤上,高、低剂量分别按 20ml /kg (用本品的 2倍浓药液 10ml )、 5ral/kg 给本品; 阳性对照组、 乙醇对照组及空白对照组分别给冯了性药酒、 55% 乙醇、 去离子水; 各组每次给药体积均为 5ml/kg, 每日给药 1次(本品高 剂量组给药 2 次), 连续 7 天。 末次给药后次日, 拉颈处死小鼠, 剖取棉 球肉芽肿,于 60°C烘箱内放置 12小时后精确称重,减去原干棉球重(20mg/ 只) 即得肉芽肿重。 与空白组比较作组间 t检验。 结果见表 6。 Take 72 mice, weighing 24-26g, ? δ is used in combination and is randomly divided into 5 groups. Each mouse was anesthetized with sodium pentobarbital, and the sterilized dry cotton ball was embedded under the aseptic operation to the right side of the back, about 2.5 cm from the surgical incision. The next day after the operation, the surface of the cotton ball was depilated 2 X 2cm 2 , apply the liquid to the skin of the hair removal area. The high and low doses are given according to 20ml /kg (10ml of concentrated solution of this product) and 5ral/kg respectively. Positive control group and ethanol control group And the blank control group were given Fengjiu medicinal liquor, 55% ethanol, deionized water; each group was administered with a volume of 5 ml/kg per dose, once a day (two doses of this product in high dose group), 7 days in a row. On the next day after the last administration, the mice were sacrificed by pulling the neck, and the cotton granuloma was taken out and placed in an oven at 60 ° C for 12 hours, then accurately weighed, minus the weight of the original dry cotton ball (20 mg / only) to obtain granuloma. weight. The t-test between groups was compared with the blank group. The results are shown in Table 6.
表 6、 本品外涂对小鼠棉球肿增生的影响结果  Table 6. Results of the external application of this product on the proliferation of mouse cotton ball
组别 n 剂量 (ml /kg) 肉芽肿重(mg) 抑制率 (%) 高剂量组 14 20 27.0±7.2** 32.5  Group n dose (ml / kg) granuloma weight (mg) inhibition rate (%) high dose group 14 20 27.0 ± 7.2** 32.5
低剂量组 14 5 32.1±7.9* 22.1  Low dose group 14 5 32.1±7.9* 22.1
冯了性组 15 5 20.1±6.0** 31.8  Feng's sexual group 15 5 20.1±6.0** 31.8
空白組 15 5 42.2 ±17.8 乙醇组 14 5 36. 3 ± 9· 5* 结果可见,高、低剂量级的肉芽肿重量分别比空白级降低 32. 5%、 22. 1%, 其中高剂量组差异有显著性意义, 与乙醇组比较差异亦有显著性意义。 提 示本品局部皮肤涂药对小鼠皮下棉球肉芽肿的增生有一定抑制作用。 Blank group 15 5 42.2 ±17.8 Ethanol group 14 5 36. 3 ± 9· 5* The results showed that the weight of granuloma in the high and low dose levels was 32.5% and 22.1% lower than the blank level, respectively, and the difference in the high dose group was significant. The difference in the ethanol group was also significant. It is suggested that the local skin application of this product can inhibit the proliferation of subcutaneous cotton granuloma in mice.
7、 本品 ig给药对小鼠棉球肉芽肿增生的影响试验  7. Effect of ig administration on the proliferation of cotton granuloma in mice
取小鼠 72只, 体重 22— 24g, $ δ兼用, 随机分为 6组。 各鼠 ig戊巴 比妥钠麻醉, 无菌操作下将灭菌干棉球(20mg )埋入背部右侧皮下, 距手 术切口约 2. 5cm, 术后次日给药: 高、 .中、 低剂量组分别按 10ml/kg (用本 品 2倍浓药液 5ml )、 5ml/kg、 2. 5ml/kg给本品; 阳性对照组给冯了性药酒 10ml/kg (挥去部份乙醇, 见材料项); 乙醇组给 27%乙醇; 空白对照组给 水。 各组给药体积均为 10ml/kg (挥去部份乙醇, 见材料项); 乙醇组给 27% 乙醇; 空白对照组给水。 各组给药体积均为 10ml/kg, 每日 igl 次, 连续 7 曰。 末次给药后次日, 拉颈处死小鼠, 剖取棉球肉芽肿, 于 60°C烘箱内 放置 16 小时后精确称重, 减去原干棉球生 (20ml/只) 即得肉牙肿重, 与 空白组比较, 作组间 t检验。 结果见表 7。  72 mice were taken, weighing 22-24 g, and $ δ was used together and randomly divided into 6 groups. Each mouse was anesthetized with sodium pentobarbital, and the sterile dry cotton ball (20 mg) was immersed in the right side of the back under the aseptic operation, about 2. 5 cm from the surgical incision. The next day after administration: high, medium, The low-dose group was given 10 ml/kg (5 ml concentrated solution of this product, 5 ml/kg, 2.5 ml/kg); the positive control group was given 10 ml/kg of medicinal liquor (waxing part of ethanol) , see material item); ethanol group gives 27% ethanol; blank control group gives water. The administration volume of each group was 10 ml/kg (partial ethanol was removed, see material item); ethanol group was given 27% ethanol; blank control group was given water. The dosage volume of each group was 10 ml/kg, igl times per day for 7 consecutive days. On the next day after the last administration, the mice were sacrificed by necking, and the cotton granuloma was taken out and placed in an oven at 60 ° C for 16 hours, then accurately weighed, minus the original dry cotton ball (20 ml / only). Swelling, compared with the blank group, for t-test between groups. The results are shown in Table 7.
表 7、 对小鼠棉球肉芽肿增生的影响结果  Table 7. Effect of cotton granuloma on mouse cotton granuloma
组别 n 剂量 (ml /kg) 肉芽肿重(mg, X 土 SD) 肿胀率 (%) 高剂量组 12 10 24. 5 ± 8. 2* 21. 1 中剂量组 12 5 24. 6 ± 9. 0* 20. 5 低剂量組 12 2. 5 22. 4 ± 6. 5** 20. 2 冯了性组 12 10 20. 1 ± 5. 1*** 35. 3  Group n dose (ml / kg) Granuloma weight (mg, X soil SD) Swelling rate (%) High dose group 12 10 24. 5 ± 8. 2* 21. 1 Medium dose group 12 5 24. 6 ± 9 0* 20. 5 Low dose group 12 2. 5 22. 4 ± 6. 5** 20. 2 Feng group 12 10 20. 1 ± 5. 1*** 35. 3
乙醇组 12 10 31. 2 ± 9. 9  Ethanol group 12 10 31. 2 ± 9. 9
空白组 12 10 27. 5 + 8. 7* 结果可见, 高、 中、 低剂量组的肉芽肿重量分别比空白组减少 21. 4%、 20. 5%、 28. 2%, 3 个组抑制率接近, 其中低剂量组差异有显著性意义, 提 示本品 ig给药对小鼠皮下棉球肉芽肿的增生可能有一定的抑制作用。 Blank group 12 10 27. 5 + 8. 7* The results showed that the granuloma weights in the high, medium and low dose groups were 21. 4%, 20.5%, 28. 2% lower than those in the blank group, respectively. The inhibition rates of the three groups were close, and the difference in the low dose group was significant. It suggests that the ig administration of this product may have a certain inhibitory effect on the proliferation of subcutaneous cotton granuloma in mice.
8、 本品局部涂药对小鼠热致痛的影响试验(热板法):  8. Test of the effect of topical application of this product on heat-induced pain in mice (hot plate method):
选取痛阀值在 10—20秒的 性小鼠 50只, 全重 20—24g, 随机均分为 5 组。 以热板法测痛: 分别将小鼠投入底板温度为 55 ± 0. 5 °C的铁盒中, 自小鼠投入铁盒至出现添后足的时间作为痛阀值。 测定药前痛阀值后 30min, 高、 中、 低剂量组分别按 16ml/kg 本品 2倍浓药液)、 8ml/kg、 5ml/kg 以本品涂双足底; 阳性对照组以冯了性药酒 8ml/kg 涂双足底; 空 白组以水涂双足; 各組涂药体积均为 8ml/kg。 分别于涂药后 30min、 60min、 90min测定各鼠的痛阀值, 以药后痛阀增值与空白组比较, 作组间 t检验。 结果见表 8。 50 mice with a pain threshold of 10-20 seconds were selected, and the total weight was 20-24 g, which were randomly divided into 5 groups. The pain was measured by the hot plate method: the mice were placed in an iron box with a bottom plate temperature of 55 ± 0.5 ° C, and the time from the time when the mouse was put into the iron box to the time when the foot was added was used as the pain threshold. 30 minutes after the pre-dose pain threshold, the high, medium and low dose groups were respectively treated with 16 ml/kg of this product 2 times concentrated solution), 8 ml/kg, 5 ml/kg to the base of the product; The medicinal liquor 8ml/kg was coated with double soles; the blank group was coated with water; both groups were coated with 8ml/kg. The pain thresholds of each rat were measured at 30 min, 60 min, and 90 min after drug application. The post-dose pain threshold was compared with the blank group for t-test. The results are shown in Table 8.
表 8、 局部涂药对小鼠热板致揭的影响结果(S. 土 SD) Table 8. Results of local application of drug on the hot plate of mice (S. Soil SD)
剂量 药后痛阀增值  Dosing
组别 n 药前痛阀值  Group n pre-drug pain threshold
(ml /kg) 30min 60min 90min 高剂量组 10 16 14.75 ±3, 33 - 0.07 ±8.29* 1.24 ±7.15* 一 0.16 ±4.43* 中剂量组 10 8 14.2 ± 3.37 1.23 ±4.24* 4.27 + 4.21*** 4.11 ±3.98* 低剂量组 10 5 13.30 ±3.29 一 2.54 ±4.05* 0.18 ±4.67* 3.19 ±4.77* 冯了性组 10 8 13.5 ±3.23 3.45 ±5.19*** 3.25 ±6.92 2.24 ±4.23* 空白组 10 0 14.1±2.95 -2.20 ±4.22* -4.10 ±3.24* -0.78 ±5.06* (ml /kg) 30min 60min 90min High dose group 10 16 14.75 ±3, 33 - 0.07 ±8.29* 1.24 ±7.15* A 0.16 ±4.43* medium dose group 10 8 14.2 ± 3.37 1.23 ±4.24* 4.27 + 4.21*** 4.11 ±3.98* Low dose group 10 5 13.30 ±3.29 A2.54 ±4.05* 0.18 ±4.67* 3.19 ±4.77* Vortex group 10 8 13.5 ±3.23 3.45 ±5.19*** 3.25 ±6.92 2.24 ±4.23* Blank group 10 0 14.1±2.95 -2.20 ±4.22* -4.10 ±3.24* -0.78 ±5.06*
结果可见, 本品中剂量组的药后 60mim、 90mim痛阀增值均高于空白组, 差异有显著性意义, 提示本品涂足似对小鼠热板致育有一定的镇痛作用。 The results showed that the value of the 60mim and 90mim pain valves in the middle dose group of this product was higher than that in the blank group. The difference was significant, suggesting that the product has a certain analgesic effect on the hot plate breeding of mice.
9、 本品 ig给药对小鼠热板致痛的影响试验(热板法)  9. The effect of ig administration on the pain caused by hot plate in mice (hot plate method)
选取痛阀值在 7—20秒的?性小鼠 60只, 体重 22— 25g, 随机均分为 5 组。 以热板法测痛: 分别将小鼠投入底板温度为 55 ± 0. 5°C的铁盒中, 自小鼠投入至出现添后足的时间作为痛阀值。 测定药前痛阀值后 30mim, 高、中、低剂量组分别按 10ml/kg (用本品 2倍农药液 5ml )、5ml/kg、2. 5ml/kg 给本品; 阳性对照组给冯了性药酒 10ml/kg (挥去部份乙醇, 见材料项); 空白对照组给水; 乙醇组给 27%乙醇。 各组 ig给药体积为 10ml/kg。 分别 于给药后 30mim、 60mim、 90mim测定各鼠的痛阀值, 以药后痛阀增值与空 白组比较, 作组间 t检验。 结果见表 9。 Choose the pain threshold in 7-20 seconds? Sixty mice, weighing 22-25 g, were randomly divided into 5 groups. The pain was measured by the hot plate method: the mice were placed in an iron box with a bottom plate temperature of 55 ± 0.5 ° C, and the time from the time when the mouse was put into the addition of the hind foot was used as the pain threshold. 30mim after the pre-dose pain threshold was measured, and the high, medium and low dose groups were given 10ml/kg (5ml of pesticide solution 2 times), 5ml/kg, 2.5ml/kg, respectively; Sexual medicinal liquor 10ml/kg (spent part of ethanol, see material item); blank control group water supply; ethanol group gave 27% ethanol. Each group of ig administration volume was 10 ml/kg. The pain thresholds of each rat were measured at 30 mim, 60 mim, and 90 mim after administration, and the post-dose pain threshold was compared with the blank group for t-test. The results are shown in Table 9.
表 9、 本品 ig给药对小鼠热板致痛的影响结果 Table 9. Effect of ig administration on the pain caused by hot plate in mice
剂量 药后痛阀增值  Dosing
. 組 别 . n 药前痛阀值  Group . n Pre-drug pain threshold
(ml /kg) 30min 60rain 90min 高剂量组 10 10 13.94 ±4.41* 10.22 ±10.70** 10.99 ± 6.27*** 7.66 ±6.92* 中剂量组 10 5 13.66 ±3.25* - 0.05 ±5.22* 4.08 ±5.99* 2.90 + 5.42* 低剂量組 10 2.5 14.33 ±4.50* - 0.74 ± 5.47* -1.25 ±4.62* 1.19 ±5.74* 冯了性组 10 10 13.5土 3.98* 4.61 + 6.38*** 6.67 + 6.14*** 7·82±7.41* 空白组 10 10 14.69 ±3.42 一 2.79 ±4.03 -3.18 ± 3.74 1.31 ±6.98 乙醇组 10 10 13.72 ±4.21* 2.17 ±1.23* 1.52 ±1.01* 2.61 ±1.92* (ml /kg) 30min 60rain 90min High dose group 10 10 13.94 ±4.41* 10.22 ±10.70** 10.99 ± 6.27*** 7.66 ±6.92* Medium dose group 10 5 13.66 ±3.25* - 0.05 ±5.22* 4.08 ±5.99* 2.90 + 5.42* Low dose group 10 2.5 14.33 ±4.50* - 0.74 ± 5.47* -1.25 ±4.62* 1.19 ±5.74* Vonogenic group 10 10 13.5 soil 3.98* 4.61 + 6.38*** 6.67 + 6.14*** 7 · 82±7.41* blank group 10 10 14.69 ±3.42 one 2.79 ±4.03 -3.18 ± 3.74 1.31 ±6.98 ethanol group 10 10 13.72 ±4.21* 2.17 ±1.23* 1.52 ±1.01* 2.61 ±1.92*
结果可见, 本品高剂量组药后 30min、 60min的痛阀增值均明显高于空 白组, 差异有显著性意义, 提示本品在较高较高剂量时 ig 给药对小鼠热 板致痛有一定的鎮痛作用, 作用维持时间约 60 分钟。 这种作用似乎非乙 醇所引起。 The results showed that the value of the pain valve at 30 min and 60 min after the high-dose group was significantly higher than that of the blank group. The difference was significant, suggesting that the product was sensitized to the hot plate of the mouse at higher doses. It has a certain analgesic effect and the duration of action is about 60 minutes. This effect appears to be caused by non-ethanol.
10、 本品 ig给药对小鼠醋酸刺激致痛的影响试验  10, the effect of this product ig administration on the stimulation of acetic acid induced pain in mice
取小鼠 60只, 体重 22— 25g, ? $各半, 随机均分为 6组。 高、 中、 低剂量组分别按 lOml/kg (用本品的 2倍浓药液 5ml )、 5ml/kg、 2. 5ml/kg 给本品, 阳性对照组给冯了性药酒 10ml/kg (挥去部分乙醇, 见材料项); 空白对照组给水; 乙醇组给 27%乙醇。均为 ig给药,给药体积均为 10ml/kg。 各鼠给药后 lh, igO. 7%醋酸 10ml/kg,记录 ig醋^^ 15min内的扭体次数, 与空白组比较, 作组间 t检验。 结果见表 10。  Take 60 mice, weighing 22-25g, ? Each half is divided into 6 groups. The high, medium and low dose groups were given 10 ml/kg (5 ml concentrated solution of this product, 5 ml/kg, 2. 5 ml/kg), and the positive control group was given 10 ml/kg of Fengjiu medicinal liquor ( Part of the ethanol was removed, see material item); blank control group was given water; ethanol group was given 27% ethanol. All were administered by ig, and the administration volume was 10 ml/kg. After the rats were administered lh, igO.7% acetic acid 10 ml/kg, the number of writhings in ig vinegar ^^ 15 min was recorded, and compared with the blank group, t-test was performed between groups. The results are shown in Table 10.
表.10、 对小鼠醋酸刺激致痛的影响结果  Table 10. Results of the effects of acetic acid-induced irritation in mice
Figure imgf000032_0001
Figure imgf000032_0001
结果可见, 与空白组比较, 本品高、 中、 低剂量组的扭体次数分别减 少 76. 9%、 68. 8%、 47. 2%, 差异均有非常显著性意义, 高剂量组与乙醇组 比较差异有显著性意义, 提示本品对小鼠醋酸刺激致痛有一定的镇痛作 用。 乙醇组与空白组比较, 差异亦有显著性意义, 可见 10ml/kg体重 27% 乙醇可能影响本品的镇痛作用。 The results showed that compared with the blank group, the number of writhing in the high, medium and low dose groups of the product was reduced by 76.9%, 68.8%, and 47. 2%, respectively. The difference was very significant. There was a significant difference in the ethanol group, suggesting that this product has an analgesic effect on the stimulation of acetic acid in mice. Compared with the blank group, the difference between the ethanol group and the blank group was also significant. It can be seen that 10 ml/kg body weight is 27%. Ethanol may affect the analgesic effect of this product.
11、 本品外涂对小鼠软组织挫伤修复的影响试验 取 δ性小鼠, 体重 29— 33g。 各鼠右后腿脱毛后作软组织挫伤造型: 将小鼠右后腿置胶垫上,以砧木贴在后腿相应部位上,用 500g法码从 14cm, 高处自由落下, 打出砧木, 木砧挤压鼠腿肌肉, 造成小鼠右后腿软组织挫 伤, 弃去皮肤破损者。 造型后据损伤情况随机分成 5组, 并随即给药: 高、 中、低剂量组分别按本品 10ml (用本品 2倍浓药液 5ml )、 5ml/kg、 2. 5ml /kg 给药; 阳性对照组及乙醇对照组分别给冯了性药酒、 55%乙醇 10ml/kg, 均 为挫伤局部皮肤涂药。 每天分两次, 给药体积均为 10ml/kg, 连续结药 7 天。 给药第 3天起每天给各鼠评分(评分标准见表 11— 1 ), 将各组得分情 况与乙醇组比较, 作组间 t检^ r, 结果见表 11— 2。 末次给药后 4小时, 处死小鼠,' 剥除右后腿皮肤, 观察其软组织挫伤修复情况, 结果见表 11— 3及所附照片。 表 11— 1、 挫伤修复评分标准  11. Effect of external application on the repair of soft tissue contusion in mice. Take δ mice and weigh 29-33g. Soft tissue contusion after depilation of the right hind leg of each mouse: Place the right hind leg of the mouse on the rubber pad, paste the rootstock on the corresponding part of the hind leg, use the 500g method to freely fall from the height of 14cm, and shoot the rootstock. The muscles of the rats are pressed, causing soft tissue contusion in the right hind leg of the mouse, and the skin is damaged. After modeling, the rats were randomly divided into 5 groups according to the injury, and then administered immediately: 10 ml of the product in the high, medium and low dose groups (5 ml of the concentrated solution of this product), 5 ml/kg, 2. 5 ml / kg The positive control group and the ethanol control group were given Fengjiu medicinal liquor and 55% ethanol in 10 ml/kg, respectively. Divided twice a day, the dosage volume was 10ml/kg, and the drug was continuously administered for 7 days. Each mouse was scored every day from the 3rd day of administration (see Table 11-1 for the scoring criteria), and the scores of each group were compared with the ethanol group for t-test between groups. The results are shown in Table 11-2. Four hours after the last administration, the mice were sacrificed, and the skin of the right hind leg was removed, and the soft tissue contusion repair was observed. The results are shown in Table 11-3 and attached photos. Table 11-1, Contusion Repair Scoring Criteria
红 斑 肿 胀 瘀 斑 表 现 得 分 表 现 得分 表 现 得分  Red spot swelling swollen plaque score score performance score
皮皱、 消肿 25%左 Skin wrinkles, swelling 25% left
有红斑 0 0. 5 消退 75%左右 0. 5 右  There are red spots 0 0. 5 fades around 75% 0. 5 right
红斑消退 0. 5 1. 0 瘀斑全消 1. 0 消肿 75%左右 Red spot disappears 0. 5 1. 0 Freckle all disappears 1. 0 Swells about 75%
1. 5  1. 5
肿胀全消 表 11一 2各组得分情况 ( 士 SD ) Swelling Table 11-2 scores of each group (SSD)
剂量  Dose
组别 n 第 3天 第 4天 第 5天 第 6天  Group n Day 3 Day 4 Day 5 Day 6
(ml /kg) 高剂量组 10 10 1.35 ± 0.41** 1.55 ±0.41** 2.15 + 0.34*** 2.65土 0.34*** 中剂量组 10 5 1, 10 ±0.52* 1.35 ±0.63* 1.90±0.52* 2.30 ±0.63* 低剂量组 10 2.5 1.00 ±0.33* 1.35 ±0.41* 1.00 ±0.54* 2.15 ±0.67* 冯了性组 10 10 1.25 ± 0.49* 1.55土 0.06** 1.95 + 0.55* 2.40 ± 0.61* 乙醇组 10 10 0.05 ±0.41 1.00 ±0.47 1.40 ±0.70 1.70±0.79 (ml /kg) High dose group 10 10 1.35 ± 0.41** 1.55 ±0.41** 2.15 + 0.34*** 2.65 soil 0.34*** Medium dose group 10 5 1, 10 ±0.52* 1.35 ±0.63* 1.90±0.52 * 2.30 ±0.63* Low dose group 10 2.5 1.00 ±0.33* 1.35 ±0.41* 1.00 ±0.54* 2.15 ±0.67* Vonogenic group 10 10 1.25 ± 0.49* 1.55 soil 0.06** 1.95 + 0.55* 2.40 ± 0.61* Ethanol Group 10 10 0.05 ±0.41 1.00 ±0.47 1.40 ±0.70 1.70±0.79
表 11— 3、 药后第 Ί天软组织挫伤修复情况(只) Table 11-3, post-medication soft tissue contusion repair (only)
结果可 见 , 本品 高、 中、 低
Figure imgf000035_0001
剂量组药后 第 3— 6天的得分均高于乙醇组, 其中高剂量组的差异有显著性意义; 高、 中低剂量组药后第 7 天的痊愈、 大部分修复灵敏均高于乙醇组, 提示本品 局部皮肤涂药, 对小鼠软组织挫伤的修复有一定的促进作用。
The results show that the product is high, medium and low.
Figure imgf000035_0001
The scores on the 3rd-6th day after the dose group were higher than those in the ethanol group, and the difference in the high dose group was significant. The recovery of the high, medium and low dose groups on the 7th day after the drug was higher than that of the ethanol. Group, suggesting that the local skin application of this product has a certain promoting effect on the repair of soft tissue contusion in mice.
12、 本品体外抗菌试验  12. In vitro antibacterial test of this product
含药培养基的制备;  Preparation of a medicated medium;
取本品 (含乙醇 55% )分别用普通肉汤培养基、 血清肉汤培养基作两倍 稀译, 成系列含药培养基, 另取 55%乙醇作同法稀释, 把各含药培养基分 装试管, 每管 1ml。  Take this product (containing 55% of ethanol) and use the common broth medium and serum broth medium for double translation, into a series of drug-containing medium, and take 55% ethanol for the same method to dilute the drug. Pack the tubes in tubes, 1 ml per tube.
菌液的制备: 将大肠杆菌、 金黄色葡萄球菌、 乙型链球菌置相应培养 基中, 在 36土 1 °C培养 24小时供试。  Preparation of bacterial solution: Escherichia coli, Staphylococcus aureus, and Streptococcus mutans were placed in the corresponding medium, and cultured at 36 ° C for 24 hours for testing.
最 d、抑菌浓度的测定: 将大肠杆菌菌液和金黄色葡萄菌菌液分别接种 于各管含药普通肉汤培养基; 乙型链球菌菌接种于各种含药血清肉汤培养 基中, 幸免为每管接种菌液 0. 1ml , 于 36 士 1 °C培养 24小时。 取各管大肠 杆菌培养物、 金黄色葡萄球菌培养物、 乙型链球菌培养物分别划线接种于 伊红美蓝琼脂平板、 甘露醇高盐琼脂平板、 血琼脂平板上置 36 ± 1 °C培养 24 小时, 观察有无细菌生长。 结果见表 12—1、 表 12—2。 同法重复试验 次, 结果相同。 Determination of the most d, bacteriostatic concentration: Escherichia coli and S. aureus were inoculated into each tube containing medicinal broth medium; Streptococcus mutans inoculated in various drug-containing serum broth In the meantime, for each tube, the inoculum was inoculated with 0.1 ml, and cultured at 36 ± 1 °C for 24 hours. Escherichia coli cultures, Staphylococcus aureus cultures, and Streptococcus mutans cultures were streaked onto Eosin blue agar plates, mannitol high-salt agar plates, and blood agar plates at 36 ± 1 °C. The cells were cultured for 24 hours to observe the presence or absence of bacterial growth. The results are shown in Table 12-1 and Table 12-2. Repeat test Times, the results are the same.
表 12—1本品体外抗菌试验结果 Table 12-1 Results of in vitro antibacterial test of this product
Figure imgf000037_0001
Figure imgf000037_0001
注: "一" 表示无细菌生长, "+,, 表示有细菌生长。 下同  Note: "One" means no bacterial growth, "+," indicates bacterial growth.
表 12—2 55%乙醇体外抗菌试验结果  Table 12-2 Results of in vitro antibacterial test of 55% ethanol
空白 55%乙醇稀释浓度  Blank 55% ethanol dilution
菌种  Strain
对照 1: 2. 5 1: 5 1: 10 1: 20 1: 40 1: 80 1: 160 1: 320 大肠杆菌 + ― - + + + + + + 金黄色葡萄球菌 + - - + + + + + + 乙型链球菌 + - - + + + + + + Control 1: 2. 5 1: 5 1: 10 1: 20 1: 40 1: 80 1: 160 1: 320 E. coli + ― - + + + + + + Staphylococcus aureus + - - + + + + + + Streptococcus B + - - + + + + + +
结果可见, 本品按 2 倍稀释法测定各供试菌的小抑菌浓度, 大肠杆菌 为 1 : 10;金黄色葡萄球菌及乙型链球菌均为 1 : 20。本品抑菌作用强于 55% 乙醇。 The results showed that the product was determined by the 2-fold dilution method for the small inhibitory concentration of each test strain, E. coli was 1:10; Staphylococcus aureus and Streptococcus mutans were 1:20. The antibacterial effect of this product is stronger than 55% ethanol.
[结语]  [End]
综上实睑结果表明: 本品局部涂药, 对小鼠耳廓毛细血管有明显的扩 张作用, 对兔耳皮下血斑吸收有一定的促进作用。 本品局部涂药及 ig 给 药, 对巴豆油所致的小鼠耳廓肿胀的有一定的抑制作用, 对小鼠皮下棉球 肉芽肿的增生亦有一定的抑制作用; 本品 ig 给药, 对醋酸所致小鼠腹膜 炎症渗出无明显影响。 本品局部涂药及 ig 给药, 对小鼠热板致痛均有一 定的镇痛作用。 本品局部涂药, 对小鼠软组织损伤的修复有一定的的促进 作用。 体外抗菌试验结果, 本品对大肠杆菌的最小抑菌浓度为 1 : 10, 对 金黄色葡萄球菌及乙型链球菌为 1 : 20。 以上活血化瘀、 消炎镇痛、 抗菌、 促进软组织损伤修复的作用, 给本品的临床应用提供了一定的动物试验依 据。  In summary, the results show that: the local application of this product has a significant expansion effect on the auricle capillaries of mice, and has a certain promoting effect on the absorption of blood spots under the ears of rabbits. The topical application of the product and ig administration have a certain inhibitory effect on the swelling of the mouse ear caused by croton oil, and also have a certain inhibitory effect on the proliferation of the subcutaneous cotton granuloma in mice; , no significant effect on the peritonitis inflammatory exudation induced by acetic acid in mice. The topical application of this product and ig administration have certain analgesic effects on the pain caused by hot plate in mice. The topical application of this product has a certain promoting effect on the repair of soft tissue damage in mice. The in vitro antibacterial test results showed that the minimum inhibitory concentration of this product on E. coli was 1:10, and that of Staphylococcus aureus and Streptococcus mutans was 1:20. The above-mentioned effects of promoting blood circulation, eliminating inflammation, relieving analgesia, antibacterial, and promoting soft tissue damage provide a certain animal test basis for clinical application of this product.
本发明的消肿止痛酊治疗急性扭挫伤、 痹病临床验证综合报告 摘要: 1994年 5月至 7月, 广西中医学院一附院、 二附院, 广西区人 民医院采用随机、 对照的方法对 324 例急性扭挫伤、 痹病患者 (另设对照 组 175 例)进行了临床验证。 结果证明消肿止痛精具有消肿止痛、 舒筋活 络、活血化瘀的功效。本組治疗急性扭挫伤和痹病的总有效率分别为 93. 3% 和 92. 6%, 疗效与玉林制药厂生产的云香精无显著差异。 本品无明显毒副 作用, 个别患者外用可发生接触性皮炎, 口服可有恶心症状, 使用时应予 注意。  The summary report of the clinical report of the treatment of acute contusion and rickets in the treatment of acute swelling and pain relief of the present invention: From May to July 1994, the First Affiliated Hospital of Guangxi College of Traditional Chinese Medicine, the Second Affiliated Hospital, and the Guangxi People's Hospital adopted a randomized and controlled method. 324 patients with acute contusion and rickets (175 patients in the control group) were clinically validated. The results showed that Xiaozhongzhitongjing has the effects of reducing swelling and relieving pain, relaxing the muscles and promoting blood circulation and removing blood stasis. The total effective rate of this group in the treatment of acute contusion and rickets was 93.3% and 92.6%, respectively. The curative effect was not significantly different from that produced by Yulin Pharmaceutical Factory. This product has no obvious toxic and side effects. Individual patients may develop contact dermatitis for external use, and may have nausea symptoms when taken orally.
消肿止痛酊系广西柳州市中药总厂生产的纯中药制剂, 具有消肿止 痛, 舒筋活络, 活血化瘀之功效, 适用于跌打扭伤、 风湿骨痛等症。 为了 险证其功效, ^据广西卫生厅、 桂卫药批 1994. 23 号关于消肿止痛酊临床 验证问题的批复, 广西中医学院一附院、 二附院, 广西区人民医院对 324 例患者进行了临床验证, 结合综合报告如下: Swelling and relieving pain is a pure Chinese medicine preparation produced by Guangxi Liuzhou Traditional Chinese Medicine Factory. Pain, Shujin Huoxue, the effect of promoting blood circulation and removing blood stasis, suitable for bruises, rheumatism and bone pain. In order to prove its efficacy, according to the approval of Guangxi Health Department and Guiwei Pharmaceuticals No. 1994. 23 on the clinical verification of swelling and painkilling, Guangxi Affiliated Hospital of the First Affiliated Hospital of the Chinese Academy of Sciences, the Second Affiliated Hospital, Guangxi People's Hospital, 324 patients Clinical validation was carried out, combined with the comprehensive report as follows:
临床资料  clinical information
治疗组与对照组共 499例。 广西中医学院一附院观察 159例, 广西中 医学院二附院观察 180例, 广西区人民医院观察 160例。  A total of 499 patients were treated in the treatment group and the control group. There were 159 cases observed in the First Affiliated Hospital of Guangxi College of Traditional Chinese Medicine, 180 cases in the Second Affiliated Hospital of Guangxi College of Traditional Chinese Medicine, and 160 cases in the Guangxi People's Hospital.
―、 一般资料  -, normal information
所纳入之观察对象均为病程在 3天以内之急性扭挫伤患者以及符合痹 病中医诊断标准, 辨证属于寒湿阻络证之痹病患者。 治疗组 324 例, 使用 消肿止痛精。 对照组 175 例, 使用广西玉林制药厂生产的云香精。 两组性 别、 年龄分布均无显著差异, 见表 1。  The subjects included were all patients with acute contusion within 3 days of the disease and those who met the diagnostic criteria of Chinese medicine for diagnosis of phlegm and blood stasis. In the treatment group, 324 patients were treated with Xiaozhongzhitongjing. In the control group, 175 cases were treated with Yunxiangjing produced by Guangxi Yulin Pharmaceutical Factory. There were no significant differences in gender and age distribution between the two groups, as shown in Table 1.
二、 诊断标准:  Second, the diagnostic criteria:
( 1 ) 急性扭挫伤:  (1) Acute contusion:
1、 有明显外伤史, 病程在 3天以内。  1. There is a history of obvious trauma, and the course of the disease is within 3 days.
2、 扭伤为间接暴力使关节发生超过正常限度的扭转, 致使附着于关 节的韧带, 肌腱和关节嚢产生部份撕裂。 常发生在踝关节, 指关节和腰推, 表现为局部疼痛、 肿胀、 瘀斑和关节活动障碍等。  2. Sprains are indirect violence that causes the joint to undergo a torsion that exceeds normal limits, causing partial tearing of the ligaments, tendons, and joints attached to the joints. Often occurs in the ankle, knuckles and lumbar push, manifested as local pain, swelling, ecchymosis and joint movement disorders.
3、 挫伤为钝物打击或碰撞所致的皮下组织和肌肉的损伤。 表现为伤 部疼痛、 肿胀、 皮肤青紫、 血肿和压痛。 重者有筋膜、 肌纤维撕裂或深部 血肿。  3. Contusion is the damage of subcutaneous tissue and muscle caused by blunt object impact or collision. It is characterized by pain, swelling, bruising of the skin, hematoma and tenderness. In severe cases, there are fascia, muscle fiber tears or deep hematoma.
( 2 )痹病  (2) rickets
1、 中医诊断标准: 关节、 肌肤、 筋骨等部位疼痛, 或肿胀晨僵、 麻 木重着, 或屈伸不利, 甚则关节肿大变形, 强直不伸、 肌肉萎缩等。 1. Diagnostic criteria for Chinese medicine: pain in joints, skin, bones, etc., or swelling of morning stiffness, hemp The wood is heavy, or the flexion and extension are unfavorable, and even the joints are swollen and deformed, the stiffness is not stretched, and the muscles are atrophied.
选择痹病中寒湿阻络证型者为观察对象, 其证型标准为: 肢体关节冷 痛沉重, 或肿胀, 局部畏寒, 皮色不红, 触之不热, 遇寒痛增, 得热痛减, 舌胖, 质淡暗, 苔白腻或白滑, 脉弦紧或弦緩。  The type of syndrome of cold and dampness obstruction in rickets is selected as the object of observation. The syndrome criteria are as follows: limb joints are cold and painful, or swollen, local chills, skin color is not red, touch is not hot, cold and pain increase, The heat is reduced, the tongue is fat, the quality is light, the moss is greasy or white, and the pulse string is tight or the string is slow.
2、 西医诊断标准: 本证涉及的西医疾病, 按该病的最新诊断标准执 行, 可参考 《临床疾病诊断依据治愈好转标准》。 观察方法  2. Diagnostic Criteria for Western Medicine: The Western medicine disease involved in this card is administered according to the latest diagnostic criteria for the disease. Refer to the “Clinical Disease Diagnosis Based on Cure Improvement Standard”. Observation method
共观察 499例, 随机分为 2组。 其中治疗组 324例 , 使用消肿止痛精。 对照组 175 例, 使用玉林制药厂生产的云香精。 用法: 外用搽涂患处, 每 次 15分钟, 每日 3次, 口服每次 lml , 饭后温开水送服, 每日 2次, 急性 扭挫伤连用 5 天, 痹病患者连用 12 天。 试脸前常规对受试者作详细体格 检查, 符合病例选择标准者即可纳入观察对象。 试验后急性扭挫伤患者第 1、 3、 5天各随诊 1次, 痹病患者每 3天随诊 1次, 询问用药情况, 记录 病情及副作用。 治疗效果用记分法评定。  A total of 499 cases were observed and randomly divided into 2 groups. Among them, 324 patients in the treatment group were treated with Xiaozhongzhitongjing. In the control group, 175 cases were treated with Yunxiangjing produced by Yulin Pharmaceutical Factory. Usage: External application of sputum to the affected area, every 15 minutes, 3 times a day, oral lml each time, warm water after meals, 2 times a day, acute contusion for 5 days, rickets for 12 days. The subject is routinely examined in detail before the face is tested, and those who meet the criteria for case selection can be included in the subject. After the test, patients with acute contusion were followed up for 1st, 3rd, and 5th, and patients with rickets were followed up once every 3 days. The medication was asked and the condition and side effects were recorded. The therapeutic effect was assessed by a score method.
疗效判断直接由观察者作出。 观察期间不用其他药物。  The efficacy judgment is directly made by the observer. No other drugs were used during the observation period.
结果  Result
一、 疗效评定标准:  First, the efficacy evaluation criteria:
(一) 急性扭挫伤疗效评定标准:  (1) Evaluation criteria for the efficacy of acute contusion:
1、 痊愈: 用药 1天内疼痛减轻, 2天内肿胀开始减轻, 3天内肿痛消 失, 关节功能恢复正常。  1. Recovery: The pain was relieved within 1 day, the swelling began to decrease within 2 days, the swelling and pain disappeared within 3 days, and the joint function returned to normal.
2、 显效: 用药 1天内疼痛减轻, 2天内肿胀开始减轻, 5天内肿痛消 失, 关节功能恢复正常。 3、 有效: 用药 1天内疼痛减轻, 2天内肿胀开始减轻, 5天内肿痛显 著减轻, 关节功能显著改善。 2. Significant effect: The pain was relieved within 1 day, the swelling began to decrease within 2 days, the swelling and pain disappeared within 5 days, and the joint function returned to normal. 3. Effective: The pain was relieved within 1 day, the swelling began to decrease within 2 days, the swelling and pain were significantly relieved within 5 days, and the joint function was significantly improved.
4、 无效: 达不到上述标准者。  4. Invalid: Those who fail to meet the above criteria.
(二)痹病疗效评定标准(主要观察近期消肿止痛效果):  (2) Evaluation criteria for the efficacy of rickets (mainly observe the effect of recent swelling and pain relief):
1、 近期临床治愈: 症状全部消失, 功能活动恢复正常。 见证总积分 减少 100%。  1. Recent clinical cure: All symptoms disappeared and functional activities returned to normal. Witness the total points reduced by 100%.
2、 显效: 全部症状消除或主要症状消除, 关节功能基本恢复, 能参 加正常工作和劳动, 见证总积分减少 61%以上。  2, markedly effective: all symptoms are eliminated or the main symptoms are eliminated, joint function is basically restored, can participate in normal work and labor, witness the total score reduced by more than 61%.
3、 有效: 主要症状基本消除, 主要关节功能基本恢复或有明显进步, 生活不能自理转为能够自理, 或者失去工作和劳动能力转为劳动和工作能 力有所恢复, 见证总积分減少 31—60%。  3. Effective: The main symptoms are basically eliminated, the main joint functions are basically restored or have significant progress, life can not be self-reasonable to be able to take care of themselves, or the loss of work and labor ability to work and work ability recovery, witness the total score reduced by 31-60 %.
4、 无效: 和治疗前相比较, 各方面均无进步, 见证总积分減少在 30% 以下。  4. Invalid: Compared with before treatment, there is no improvement in all aspects, and the total score is reduced to less than 30%.
二、 治疗效果:  Second, the treatment effect:
( 1 )对各种症状、 体征的影响: 见表 1一 4。 从表中可看出两种病证 治疗组和对照组患者治疗后各见证积分下降非常显著 (p < 0. 01 = , 提示 两种药物对急性扭挫伤和寒湿阻络型痹病均有较好的治疗作用, 治疗后症 状体征改善非常明显。 从表 3还可看出急性扭挫伤治疗组肿胀开始减轻时 间明显短于对照组( p < 0. 05 =。  (1) Effects on various symptoms and signs: See Table 11-4. It can be seen from the table that the scores of the witnesses in the two treatment groups and the control group decreased significantly after treatment (p < 0.01), suggesting that both drugs have acute contusion and cold-dampness rickets. Good therapeutic effect, the symptoms and signs improved after treatment is very obvious. From Table 3, it can be seen that the swelling time of the acute contusion treatment group was significantly shorter than that of the control group (p < 0.05].
( 2 ) 治疗组与对照组疗效比较: 治疗组急性扭挫伤 150 例, 显效率 和总有效率分别为 52%和 93. 3%; 痹病 (外用) 148例, 显效率和总有效率 分别为 41. 9%和 92. 6%; 痹病 (外用 +内服) 26例, 显效率和总有效率分别 为 46. 2%和 92. 3%; 对照组急性扭挫伤 70例, 显效率和总有效分别为 45. 7% 和 80%; 痹病 (外用) 76例, 显效率和总有效率分别为 46. 1°/。和 89. 5%; 痹 病 (外用加内服) 29 例, 显效率和总有效率分别为 41. 4%和 86. 2%。 治疗 組与对照組疗效差异比较用 Ridi t 分析法均无显著意义(p〉0. 05 ), 见表 Ή乍用 (2) Comparison between the treatment group and the control group: 150 cases of acute contusion in the treatment group, the effective rate and total effective rate were 52% and 93.3%, respectively; 148 cases of rickets (external), significant efficiency and total effective rate respectively 41.9% and 92.6%; 26 cases of rickets (external + internal), the effective rate and total effective rate were 46.2% and 92.3%, respectively; 70 cases of acute contusion in the control group, markedly efficient The total effective rate is 45.7% And 80%; rickets (external) in 76 cases, the marked efficiency and total effective rate were 46.1 ° /. And the total effective rate was 41.4% and 86.2%, respectively, in 29 cases of rickets (external and internal). There was no significant difference between the treatment group and the control group by Ridi t analysis (p>0.05).
治疗组 324 例, 在观察期间有 4 例急性扭挫伤患者(p=0. 061 , 无显 著性)发生轻度接触性皮炎, 用药后皮肤瘙痒; 有 1 例痹病患者(P=0. 5 ) 内服后出现恶心, 停药后消失。 对照组 175例, 在观察期间有 3例急性扭 挫伤惠者(P=0. 122)发生接触性皮炎, 2 例痹病患者(p=0. 25 ) 内月 出现 恶心。  There were 324 patients in the treatment group. During the observation period, 4 patients with acute contusion (p=0.061, no significant) developed mild contact dermatitis, and the skin was itchy after treatment; 1 patient with rickets (P=0. 5 Disgusting after oral administration, disappeared after stopping the drug. In the control group, 175 patients had contact dermatitis in 3 patients with acute contusion during the observation period (P=0.122), and nausea occurred in 2 patients with rickets (p=0. 25).
消肿止痛酊治疗风寒湿证痹病、 急性扭挫伤的临床试验小结 消肿止痛酊系广西花红药业厂根据传统的中医药理论与经验生产的中 药制剂, 具有祛寒化湿, 驱风通络, 活血化瘀, 消肿止痛的功效, 用于风 寒湿痹、 关节疼痛、 跌打损伤, 瘀血肿痛等症。 我院于 2001年 5月至 2001 年 9月对消肿止痛酊进行了临床试验, 结果小结如下: 对象与方法  Clinical study on the treatment of phlegm and cold phlegm and phlegm and acute contusion in the treatment of cold and dampness syndrome. Xiaojie Xiaozhongzhitong 酊 is a traditional Chinese medicine preparation produced by Guangxi Huahong Pharmaceutical Factory based on traditional Chinese medicine theory and experience. It has cold and dampness, and it is popular. Collateral, activating blood circulation, relieving swelling and relieving pain, used for cold and dampness, joint pain, bruises, hemorrhage and so on. Our hospital conducted a clinical trial on swelling and painkillers from May 2001 to September 2001. The results are summarized as follows: Objects and methods
本次验证确定合格受试对象的诊断标准、 纳入标准、 排除标准、 病例 分组、 两组药物的用法用量、 观察项目与方法、 疗效判定标准、 不良反应 的观察以及统计学的处理方法均按照 《消肿止痛酊治疗风寒湿证痹病、 急 性扭挫伤的临床试验方案》 实施。  This verification determines the diagnostic criteria, inclusion criteria, exclusion criteria, case grouping, usage and dosage of the two groups of drugs, observation items and methods, efficacy criteria, adverse reaction observations, and statistical treatment methods for qualified subjects. The implementation of the clinical trial plan for the treatment of phlegm and acute contusion in the treatment of wind and cold dampness syndrome.
1、 分组: 查随机排列表, 治疗组与对照組按 5: 3进行区组随机分组。 1. Grouping: Check the random row list, and the treatment group and the control group are randomly grouped by 5:3.
2、 用量疗程和给药方法: (1)治疗组与开放治疗组: 100例, 使用消肿止痛酊, 将药液涂于患处, 搓揉, 每曰 6次。 2. Dosage treatment and administration method: (1) Treatment group and open treatment group: 100 cases were treated with swelling and painkilling, and the drug solution was applied to the affected area, sputum, 6 times per sputum.
(2)对照组: 30 例, 使用痛肿灵 [广西龙州制药厂生产, 桂卫药准字 ( 1982 )第 041001号], 将药液涂于患处, 搓揉, 痹病者每日 3次, 急性 扭挫伤者, 每曰 6次。  (2) Control group: 30 cases, using painful swelling [produced by Guangxi Longzhou Pharmaceutical Factory, Guiwei Medicine Zhunzi (1982) No. 04101], applying the liquid to the affected area, sputum, rickets daily 3 Times, acute contusion, 6 times per sputum.
(3)疗和: 7天。  (3) Treatment and: 7 days.
(4)试验疗程内停用其他类似药物。  (4) Other similar drugs were discontinued during the trial treatment.
3、 统计方法: 等级资料用 Ridit分析, 计数资料用 X2检验, 计量资料 用 t (u)检验。 3. Statistical methods: Grade data is analyzed by Ridit, count data is analyzed by X 2 , and measurement data is checked by t (u).
结果  Result
一、 一般资料与可比性检查:  I. General information and comparability check:
1、 性别比较:  1. Gender comparison:
表 1性别 (例) 比较(X2检验) Table 1 Gender (example) Comparison (X 2 test)
Figure imgf000043_0001
Figure imgf000043_0001
注: 治疗组与对照组性别比较, X2=1.78, P>0.05, 无显著性差异。 Note: The treatment group was compared with the control group, X 2 =1.78, P>0.05, no significant difference.
2、 年龄比较:  2. Age comparison:
表 2年龄(岁) 比较( Ridit分析 ) Table 2 Age (years) Comparison ( Ridit analysis)
例数 -27 -37 -47 -57 -58 治疗组 50 12 15 7 11 5 对照组 30 12 8 4 3 3 开放组 50 7 20 10 10 3 注: 治疗组与对照组性别比较, X2=l.39, P>0.05, 无显著性差异。 Number of cases -27 -37 -47 -57 -58 Treatment group 50 12 15 7 11 5 Control group 30 12 8 4 3 3 Open group 50 7 20 10 10 3 Note: The treatment group was compared with the control group, X 2 = 1.39, P> 0.05, no significant difference.
3、 病种比较: 3. Comparison of disease types:
表 3 病种比较(X2检验) Table 3 Comparison of disease types (X 2 test)
Figure imgf000044_0001
Figure imgf000044_0001
注: 治疗組与对照组病种分布相同, 无差异。 Note: The treatment group and the control group have the same distribution, no difference.
4、 两组病程比较:  4, the two groups of disease comparison:
表 4 两组病程 (天) 比较(Ridit分析) Table 4 Comparison of disease duration (days) between two groups (Ridit analysis)
Figure imgf000044_0002
Figure imgf000044_0002
注: 急性扭挫治疗组与对照组比较, U=0.54, P> 0.05, 差异无显著性意 义。 Note: Compared with the control group, the acute torsion treatment group had U=0.54, P>0.05, and the difference was not significant.
5、 治疗前总积分比较:  5. Comparison of total points before treatment:
表 5 治疗前总积分 ( ± SD ) 比较( t检验 ) 痹病 例数 治疗前积分 Table 5 Total score before treatment (± SD) Comparison (t test) 痹 number of cases before treatment points
开放組 50 23.29 ±2.34 急性扭挫伤 例数 治疗前积分 治疗组 50 19.71 ±5.13 对照组 30 21.80 ±4.97 注: 急性扭挫伤治疗组与对照组治疗前总积分比较, U=1.80, Ρ> 0.05, 差异无显著性意义。 上述治疗前可比性检测表明, 两组在性别、 年龄、 病种、 病程、 治疗 前病情等比较, 差异均无显著性意义。 提示影响两组预后的主要因素具有 均衡性。  Open group 50 23.29 ± 2.34 Acute contusion injury number before treatment in the treatment group 50 19.71 ± 5.13 Control group 30 21.80 ± 4.97 Note: The total score of the acute contusion treatment group and the control group before treatment, U = 1.80, Ρ > 0.05, The difference was not significant. The above pre-treatment comparison showed that there was no significant difference between the two groups in terms of gender, age, disease type, disease course, and pre-treatment condition. It is suggested that the main factors affecting the prognosis of the two groups are balanced.
二、 疗效比较: Second, the efficacy comparison:
1、 总疗效比较:  1, the total effect comparison:
表 6 总疗效比较(Ridit分析) Table 6 Comparison of total efficacy (Ridit analysis)
Figure imgf000045_0001
Figure imgf000045_0001
注: 治疗组与对照组总疗效比较, U=0.44, P>0.05, 差异无显著性意义。 2、 不同病种疗效比较: Note: The total efficacy of the treatment group and the control group were compared, U=0.44, P>0.05, the difference was not significant. 2. Comparison of efficacy of different diseases:
(1)痹病疗效分布:  (1) Distribution of curative effect:
表 7 痹病疗效分布 Table 7 Distribution of caries
例数 显效( ) 有效(% ) 无效( % ) 总有效(% ) 开放组 50 16 ( 32.0) 28 (56.0) 6 (12.0) 44 (88.0) The number of cases is markedly effective ( ) is valid (% ) is invalid ( % ) is always valid (% ) Open Group 50 16 ( 32.0) 28 (56.0) 6 (12.0) 44 (88.0)
(2)急性扭挫伤疗效比较: (2) Comparison of the effects of acute contusion:
表 8 急性扭挫伤疗效比较( Ridit分析 ) Table 8 Comparison of the effects of acute contusion ( Ridit analysis)
Figure imgf000046_0001
Figure imgf000046_0001
注: 治疗组与对照组总疗效比较, U=0.44, P>0.05 , 差异无显著性意义。 3、 治疗后临床症状疗效比较: Note: The total efficacy of the treatment group and the control group, U = 0.44, P > 0.05, the difference was not significant. 3. Comparison of clinical symptoms after treatment:
(1) 痹病患者治疗后临床症状疗效比较(Ridit分析):  (1) Comparison of clinical symptoms after treatment of rickets (Ridit analysis):
表 9 痹病患者治疗后临床症状疗效比较 Table 9 Comparison of clinical symptoms after treatment of rickets
Figure imgf000046_0002
Figure imgf000046_0002
注: 痹病开放治疗组患者治疗后, 各症状均有明显改善, P<G.01。 Note: After treatment in the open treatment group, the symptoms were significantly improved, P < G.01.
(2) 急性扭挫伤患者治疗后临床症状疗效比较(Ridit分析) 表 10 急性扭挫伤患者治疗后临床症状疗效比较 (2) Comparison of clinical symptoms after treatment of patients with acute contusion (Ridit analysis) Table 10 Comparison of clinical symptoms after treatment of patients with acute contusion
例数 改善 3级 改善 2级 改善 1级 无改善 U值 * 自觉疼痛 治疗组 50 1 18 31 0 0. 9 对照组 30 0 8 22 0  Number of cases Improved Level 3 Improvement Level 2 Improvement Level 1 No improvement U value * Self-conscious pain Treatment group 50 1 18 31 0 0. 9 Control group 30 0 8 22 0
压 痛 治疗组 50 1 23 25 1 0. 7 对照组 30 0 17 11 2 Pain treatment group 50 1 23 25 1 0. 7 Control group 30 0 17 11 2
肿 胀 治疗组 42 2 6 31 3 1. 31 对照组 27 1 10 14 2 Swollen treatment group 42 2 6 31 3 1. 31 control group 27 1 10 14 2
痹 斑 治疗组 43 0 15 26 2 1. 05 对照组 29 1 15 9 4 痹 spot treatment group 43 0 15 26 2 1. 05 control group 29 1 15 9 4
活动障碍 治疗组 37 2 16 19 0 0. 85 对照组 25 1 8 16 0 Activity disorder treatment group 37 2 16 19 0 0. 85 control group 25 1 8 16 0
注: *为治疗组与对照组比较 ϋ值。 Note: * The devaluation value was compared between the treatment group and the control group.
急性扭挫伤两组患者治疗后, 各症状均有明显改善, Ρ<0.01; 但治疗组 与对照组比较, Ρ>0.05, 差异无显著性意义。 After treatment, the symptoms of both groups of patients with acute contusion were significantly improved, Ρ<0.01; however, compared with the control group, Ρ>0.05, the difference was not significant.
(3)治疗后疼痛开始减轻时间 (X土 SD) 比较(U检验):  (3) Time to reduce pain after treatment (X soil SD) Comparison (U test):
表 11 治疗后疼痛开始减轻时间 (天) 比较  Table 11 Time to reduce pain after treatment (days)
Figure imgf000048_0001
Figure imgf000048_0001
*为治^组与对照组比较 U值。  * The U value was compared between the control group and the control group.
急性扭挫伤治疗组与对照组患者治疗后, 疼痛开始减轻时间无明显差 异, Ρ>0.05。  After the treatment of the acute contusion treatment group and the control group, there was no significant difference in the time of pain reduction, Ρ>0.05.
四、 安全性检测: Fourth, security testing:
(1)血常规: 治疗前检测了 67例, 其中在正常范围的 67例治疗后复查, 均未见异常。  (1) Blood routine: 67 cases were detected before treatment, and 67 cases were reviewed after treatment in the normal range, and no abnormalities were found.
(2)尿常规: 治疗前检测了 67例, 其中在正常范围的 67例治疗后复查, 均未见异常。  (2) Urine routine: 67 cases were detected before treatment, and 67 cases in the normal range were reviewed after treatment. No abnormalities were found.
(3) 大便常规: 治疗前检测了 67 例, 其中在正常范围的 67 例治疗后复 查, 均未见异常。  (3) Stool routine: 67 cases were detected before treatment, and 67 cases were treated after normal treatment, and no abnormalities were found.
(4)心电图: 治疗前检测了 67例, 其中在正常范围的 67例治疗后复查, 均未见异常。  (4) Electrocardiogram: 67 cases were detected before treatment, and 67 cases were reviewed after treatment in the normal range. No abnormalities were found.
(5) ALT: 治疗前检测了 67例, 其中在正常范围的 67例治疗后复查, 均 未见异常。 (5) ALT: 67 cases were detected before treatment, of which 67 cases were treated after the normal range, No abnormalities.
(6) BCr: 治疗前检测了 67例, 其中在正常范围的 67例治疗后复查, 均 未见异常。  (6) BCr: 67 cases were detected before treatment, and 67 cases were reviewed after treatment in the normal range. No abnormalities were found.
(7) BUN: 治疗前检测了 67例, 其中在正常范围的 67例治疗后复查, 均 未见异常。  (7) BUN: 67 cases were detected before treatment, and 67 cases were reviewed after treatment in the normal range. No abnormalities were found.
2、 对照组:  2. Control group:
(1)血常规: 治疗前检测了 20例, 其中在正常范围的 20例治疗后复查, 均未见异常。  (1) Blood routine: 20 cases were detected before treatment, and 20 cases were reviewed after treatment in the normal range. No abnormalities were found.
(2)尿常规: 治疗前检测了 20例, 其中在正常范围的 20例治疗后复查, 均未见异常。  (2) Urine routine: 20 cases were detected before treatment, and 20 cases were reviewed after treatment in the normal range. No abnormalities were found.
(3) 大便常规: 治疗前检测了 20 例, 其中在正常范围的 20 例治疗后复 查, 均未见异常。  (3) Stool routine: 20 cases were detected before treatment, and 20 cases were treated after normal treatment, and no abnormalities were found.
(4)心电图: 治疗前检测了 73例, 其中在正常范围的 73例治疗后复查, 均未见异常。  (4) Electrocardiogram: 73 cases were detected before treatment, and 73 cases in the normal range were reviewed after treatment. No abnormalities were found.
(5) ALT: 治疗前检测了 20例, 其中在正常范围的 20例治疗后复查, 均 未见异常。 (5) ALT: 20 cases detected before treatment, wherein the treatment of the normal range after review of 20 patients were normal.
(6) BCr: 治疗前检测了 73例, 其中在正常范围的 73例治疗后复查, 均 未见异常。  (6) BCr: 73 cases were detected before treatment, and 73 cases in the normal range were reviewed after treatment, and no abnormalities were found.
(7) BUN: 治疗前检测了 20例, 其中在正常范围的 20例治疗后复查, 均 未见异常。 (7) BUN: before treatment examined 20 cases, 20 cases of normal after treatment range review, were normal.
五、 不良反应观察: 两组用药后均未出现不良反应症状。 V. Observation of adverse reactions: No adverse reactions were observed after administration of the two groups.

Claims

权利要求 Rights request
1、 一种治疗跌打损伤、 风湿骨痛的中药制剂, 其特征在于该中药制剂 包括下述重量份的原料药和药剂学可接受的赋形剂或辅料: A traditional Chinese medicine preparation for treating bruises and rheumatic bone pain, characterized in that the traditional Chinese medicine preparation comprises the following raw materials and pharmaceutically acceptable excipients or excipients:
防风 30- 80 荆芥 30- 80 细辛 30-80 牛膝 30-80 川芎 30-80 徐长卿 30 - 80 莪术 30- 80 大罗伞 85- 120 小罗伞 55-90 两面针 85- 120 三棱 55-90。  Windproof 30- 80 Nepeta 30-80 Asarum 30-80 Achyranthes 30-80 Chuanxi 30-80 Xu Changqing 30 - 80 Qishu 30-80 Da Luo Umbrella 85- 120 Ronaldinho 55-90 Double-sided needle 85- 120 Triangular 55-90.
2、 按照权利要求 1 所述的一种治疗跌打损伤、 风湿骨痛的中药制剂, 其特征在于该中药制剂还包括下述重量份的原料药和药剂学可接受的 赋形剂或辅料:  2. A traditional Chinese medicine preparation for treating bruises and rheumatic bone pain according to claim 1, characterized in that the traditional Chinese medicine preparation further comprises the following bulk parts of the bulk drug and the pharmaceutically acceptable excipient or auxiliary:
樟脑 40-90 薄荷脑 40-90。 Camphor 40-90 Menthol 40-90.
3、 按照权利要求 2所述的一种治疗跌打损伤、 风湿骨痛的中药制剂, 其特征在于该中药制剂还包括下述重量份的原料药和药剂学可接受的 赋形剂或辅料:  3. A traditional Chinese medicine preparation for treating bruises and rheumatic bone pain according to claim 2, characterized in that the traditional Chinese medicine preparation further comprises the following bulk parts of the bulk drug and the pharmaceutically acceptable excipient or auxiliary:
桂枝 30 - 80 白芷 30- 80 红杜仲 55-90。 Guizhi 30 - 80 White Stork 30- 80 Red Eucommia 55-90.
4、 按照权利要求 3 所述的一种治疗跌打损伤、 风湿骨痛的中药制剂, 其特征在于该中药制剂还包括下述重量份的原料药:  4. A traditional Chinese medicine preparation for treating bruises and rheumatic bone pain according to claim 3, characterized in that the traditional Chinese medicine preparation further comprises the following bulk ingredients:
木香 30-80 五加皮 30- 80 黄藤 80-105 栀子 85-120。 Woody 30-80 Wujiapi 30-80 Huangteng 80-105 Scorpion 85-120.
5、 按照权利要求 4 所述的一种治疗跌打损伤、 风湿骨痛的中药制剂, 其特征在于该中药制剂还包括下述重量份的原料药:  5. A traditional Chinese medicine preparation for treating bruises and rheumatoid bone pain according to claim 4, wherein the traditional Chinese medicine preparation further comprises the following weight parts of the raw material medicine:
沉香 20-40。 Agarwood 20-40.
6、 按照权利要求 5所述的中药制剂, 其特征在于所述原料药的重量份 配比为: 6. The traditional Chinese medicine preparation according to claim 5, wherein the weight ratio of the raw material medicine is:
木香 70 防风 60 荆芥 70  Woody 70 windproof 60 Nepeta 70
细辛 70 五加皮 60 桂枝 50  Asarum 70 Wujiapi 60 Guizhi 50
牛膝 70 川芎 50 徐长卿 40  Achyranthes 70 Sichuan Chuan 50 Xu Changqing 40
白芷 70 莪术 60 红杜仲 70  White 芷 70 莪 60 60 Red Eucommia 70
大罗伞 110 小罗伞 60 两面针 100  Big Luo umbrella 110 small Luo umbrella 60 double needle 100
黄藤 85 栀子 90 三棱 85  Yellow vine 85 栀子 90 三棱 85
沉香 25 樟脑 80 薄荷脑 50。  Agarwood 25 camphor 80 menthol 50.
7、 根据权利要求 5 所述的中药制剂 其特征在于所述原料药的重量 份配比为:  7. The traditional Chinese medicine preparation according to claim 5, wherein the weight ratio of the raw material medicine is:
木香 47 防风 47 荆芥 47  Woody 47 windproof 47 Nepeta 47
细辛 47 五加皮 47 桂枝 47  Asahi 47 Wujiapi 47 Guizhi 47
牛膝 47 川芎 47 徐长卿 47  Achyranthes 47 Chuanxi 47 Xu Changqing 47
白芷 70 莪术 47 红杜仲 70  白芷70 莪术 47 红杜仲 70
大罗伞 100 小罗伞 70 两面针 100  Big Luo umbrella 100 small Luo umbrella 70 double needle 100
黄藤 80 栀子 100 三棱 70  Yellow rattan 80 scorpion 100 three-sided 70
沉香 32. 5 樟脑 55 薄荷脑 55。  Agarwood 32. 5 Camphor 55 Menthol 55.
8、 根据权利要求 5 所述的中药制剂 其特征在于所述原料药的重量 份配比为:  8. The traditional Chinese medicine preparation according to claim 5, wherein the weight ratio of the raw material medicine is:
木香 35 防风 60 荆芥 35  Woody 35 windproof 60 Nepeta 35
细辛 40 五加皮 80 桂枝 40  Asahi 40 Wujipi 80 Guizhi 40
牛膝 40 川芎 50 徐长卿 40 白芷 35 莪术 50 红杜仲 80 Achyranthes 40 Chuanxi 50 Xu Changqing 40 White 芷35 莪术50 Red Eucommia 80
大罗伞 110 小罗伞 80 两面针 90  Big Luo umbrella 110 small Luo umbrella 80 double needle 90
黄藤 95 栀子 110 三棱 80  Yellow rattan 95 scorpion 110 triangular 80
沉香 40 樟脑 40
Figure imgf000052_0001
Agarwood 40 camphor 40
Figure imgf000052_0001
9、 根据权利要求 1-8任一所述的中药制剂, 其特征在于该中药制剂为 酊剂、 7 剂、 或乳剂。  The traditional Chinese medicine preparation according to any one of claims 1 to 8, characterized in that the traditional Chinese medicine preparation is an expectorant, a seventh dose, or an emulsion.
10、 一种制备治疗跌打损伤、 风湿骨痛的中药制剂的制备方法, 其特 征在于包括以下步驟:  10. A method for preparing a traditional Chinese medicine preparation for treating bruises and rheumatic bone pain, which comprises the following steps:
将上述除樟脑、 薄荷脑外的其余原料药粉碎成粗粉, 依照制备流浸膏 剂与浸膏剂的渗漉法, 用 7000 ~ 8000重量份的 50- 95 %乙醇作溶剂, 浸渍 15-30 小时后, 室温下以每分钟 1-10 ml 的速度緩緩渗漉, 收集漉液, 另 器保存; 取樟脑、 薄荷脑加 500 ~ 800重量份的 50-95 %乙醇溶解后, 与上 述漉液混匀, 静置 20-72小时, 滤过, 即得酊剂。  The above-mentioned other raw materials other than camphor and menthol are pulverized into a coarse powder, and immersed for 15-30 hours by using 7000 to 8000 parts by weight of 50-95% ethanol as a solvent according to a percolation method for preparing a flow extract and an extract. After that, slowly percolate at a rate of 1-10 ml per minute at room temperature, collect the sputum, and store it again; take the camphor and menthol and add 500-800 parts by weight of 50-95% ethanol to dissolve, and the above sputum Mix well, let stand for 20-72 hours, filter, and get the tincture.
11、 根据权利要求 9所述的中药制剂, 其特征在于: 渗漉时用 53 %乙 醇作溶剂, 浸渍 28小时。  The traditional Chinese medicine preparation according to claim 9, which is characterized in that it is impregnated with 53% of ethanol as a solvent for 28 hours.
PCT/CN2005/001679 2005-01-18 2005-10-12 Traditional chinese medicament for treating injuries from falls, rheumatism and ostealgia and method for manufacture thereof WO2006076844A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN200510002239.3 2005-01-18
CN2005100022393A CN1660355A (en) 2005-01-18 2005-01-18 Chinese materia medica preparation for treating wound, rheumatic bone ache and preparing method

Publications (1)

Publication Number Publication Date
WO2006076844A1 true WO2006076844A1 (en) 2006-07-27

Family

ID=35010092

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2005/001679 WO2006076844A1 (en) 2005-01-18 2005-10-12 Traditional chinese medicament for treating injuries from falls, rheumatism and ostealgia and method for manufacture thereof

Country Status (2)

Country Link
CN (1) CN1660355A (en)
WO (1) WO2006076844A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113855649A (en) * 2021-06-30 2021-12-31 杨兴 Medicine of Lingxian Tougu bone pain-relieving paste mainly containing clematis root and speranskia herb and preparation method thereof

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101138594B (en) * 2006-09-04 2011-09-07 广西壮族自治区花红药业股份有限公司 Quality control method of traditional chinese medicine preparation for treating traumatic injury and rheumatism ostealgia
CN100998827B (en) * 2006-12-28 2010-05-12 陆宏成 Decoction for treating waist sprain and its preparation method
CN101766723B (en) * 2008-12-31 2013-08-21 广西壮族自治区花红药业股份有限公司 Chinese medicine preparation for treating traumatic injury and rheumatic pain and preparation method thereof
CN101766724B (en) * 2008-12-31 2013-08-14 广西壮族自治区花红药业股份有限公司 Chinese medicine preparation for treating traumatic injury and rheumatic pain and preparation method thereof
CN101991811B (en) * 2009-08-26 2012-02-22 广西玉林制药有限责任公司 Traditional Chinese medicine composition for treating rheumatism arthralgia, cold headache, abdominal cavity pain and chilblain and preparation method thereof
CN101780145B (en) * 2010-03-26 2012-01-04 秦彩玲 Medical stone mineral health-care product
CN101869601B (en) * 2010-06-28 2012-04-25 潘冠军 External veterinary medicament
CN106389697A (en) * 2016-11-02 2017-02-15 杨均初 Traditional Chinese medicine composition for treating rheumatic ostealgia and preparation method of traditional Chinese medicine composition for treating rheumatic ostealgia
CN109568539A (en) * 2018-12-13 2019-04-05 广州裕百草生物科技有限公司 A kind of Chinese traditional compound medicine for treating muscles and bones strain, treating rheumatic ostealgia, cold-dampness silt resistance
CN111494390B (en) * 2020-05-18 2022-08-19 南通大学 New application of betulin derivative in preparing medicine for repairing nerve injury
CN114796322B (en) * 2022-06-10 2023-11-28 广西民生堂中药研制有限公司 Traditional Chinese medicine preparation for treating swelling and pain caused by injuries from falls and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1063945C (en) * 1995-09-25 2001-04-04 石建民 External compress paste for discopathy
CN1294003A (en) * 1999-10-29 2001-05-09 武常流 Chinese patent medicine for promoting blood circulation and strengthening bone and its preparing method

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1063945C (en) * 1995-09-25 2001-04-04 石建民 External compress paste for discopathy
CN1294003A (en) * 1999-10-29 2001-05-09 武常流 Chinese patent medicine for promoting blood circulation and strengthening bone and its preparing method

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
COMMITTEE OF PHARMACOPOEIA, MINISTRY OF HEALTH, P.R.C.: "Standard of Drugs by Ministry of Health of P.R.C.", vol. 12, 1997, TCM FORMULATION, pages: 161 *
XU ZEHONG ET AL., LISHIZHEN MEDICINE AND MATERIA MEDICA RESEARCH, vol. 10, no. 12, 1999, pages 950 - 953 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113855649A (en) * 2021-06-30 2021-12-31 杨兴 Medicine of Lingxian Tougu bone pain-relieving paste mainly containing clematis root and speranskia herb and preparation method thereof

Also Published As

Publication number Publication date
CN1660355A (en) 2005-08-31

Similar Documents

Publication Publication Date Title
WO2006076844A1 (en) Traditional chinese medicament for treating injuries from falls, rheumatism and ostealgia and method for manufacture thereof
CN103721131B (en) A kind of Chinese medicine suppository and its preparation method treating women&#39;s chronic pelvic inflammatory disease
CN102091203B (en) External traditional Chinese medicine preparation for treating chronic wounds and preparation method thereof
CN102198236B (en) Chinese medicine composition for treating acute sinusitis and preparation method thereof
CN102205026B (en) Chinese medicinal composition for treating children chronic sinusitis and preparation method thereof
CN103041173A (en) Traditional Chinese medicine external preparation for curing dermatitis and eczema and preparing method thereof
CN103169928A (en) Externally applied traditional Chinese medicine composition for treating dysmenorrhea, as well as preparation method and application thereof
CN103705751B (en) Chinese medicine composition being used for the treatment of lumbago due to pathogenic wind-dampness and preparation method thereof
CN102178877B (en) External preparation for treating eczema of scrotum and preparation method thereof
CN102772712B (en) Traditional Chinese medicine composition for treating heat-toxicity, flourishing and blood stasis type diabetic foot
CN101028325B (en) Medicinal composition containing sailonggu, and its preparation and quality detection method
CN104906465A (en) Traditional Chinese medicine blood-stasis dispersing composition for treating woman chronic pelvic inflammation and preparation method thereof
CN1709302A (en) Chinese medicine formulation for treating chronic pelvic inflammation and its preparing method
CN104147538A (en) Traditional Chinese medicine preparation for treating diabetes foot in dampness-heat toxin-abundant type and preparation method thereof
CN104706953A (en) Traditional Chinese medicine preparation for treating chronic cervicitis
CN104524174A (en) Traditional Chinese medicine composition for treating rheumatic arthralgia and preparation method thereof
CN103721138A (en) External traditional Chinese medicinal preparation for treating acne rosacea and preparation method thereof
CN103520427B (en) Traditional Chinese medicine for treating body-resistance-weak and pathogen-strong type chronic osteomyelitis and preparation method thereof
CN103054991B (en) Traditional Chinese medicine composition for treating lower abdominal discomfort, as well as preparation method and use thereof
CN102357147B (en) Chinese medicine composite tincture capable of diminishing inflammation, relieving pain and preventing viruses and preparation method thereof
CN105031380A (en) Drug for oral local anesthesia of pregnant woman and preparation method thereof
CN100488547C (en) Pharmaceutical composition for treating tinea and complication thereof
CN103920010A (en) Medicinal composition with bleeding-stopping, pain-relieving and inflammation-diminishing effects, preparation method and application thereof
CN105362944A (en) Traditional Chinese medicine ointment for treating orthopedics sprain and contusion
CN104707124A (en) Traditional Chinese medicine preparation for treating chronic endometritis

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 05795408

Country of ref document: EP

Kind code of ref document: A1

WWW Wipo information: withdrawn in national office

Ref document number: 5795408

Country of ref document: EP